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ABSTRACT
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ENZYMES
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Lisa S. Mueller
The University of Wisconsin-Milwaukee, 2016
Under the Supervision of Professor Nicholas R. Silvaggi

The acetatoacetate decarboxylase-like superfamily (ADCSF) is a largely unexplored group
of enzymes that may be a potential source of new biocatalysts. Bioinformatic analysis has
grouped these approximately 2000 enzymes into seven different families based on comparison
of predicted active site residues. To date, only the prototypical ADCs (Family I) that catalyze the
decarboxylation of acetoacetate have been studied. Analysis of gene context suggests that Family
V contains predominantly enzymes predicted to be involved in secondary metabolism. On
average, these share about 20% sequence identity to the true ADCs. To learn more about the
diversity of chemistries performed by members of Family V, we have been studying two enzymes
annotated as "acetoacetate decarboxylase" in the GenBank database. These are Sbi_00515 from
Streptomyces bingchenggensis and Swit_4259 from Sphingomonas wittichii. Steady state
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analyses of these enzymes demonstrate that both lack decarboxylase activity with any of the
substrates tested. This was surprising given that the crystal structures of both enzymes show that
their overall folds are almost indistinguishable from that of the prototypical ADCs, though the
quaternary structures are different. An important observation from the bioinformatic and
crystallographic analyses is that the catalytic lysine and putative acid/base catalyst residues of
the true ADCs are retained in both groups of enzymes, but the active site architectures are
different. Specifically, two residues shown to be important for the acetoacetate decarboxylase
reaction, Arg29 and Glu61 in Clostridium acetobutylicum ADC (CaADC), are not retained in the
Family V enzymes. Site-directed mutagenesis, steady state and transient kinetics, and mass
spectroscopy data suggest evidence for reversible aldolase-dehydratase and retro-aldolase
activities mediated through a Schiff-base mechanism. These are the first Schiff-base-forming
aldolases that do not use the TIM barrel fold. Although the physiologically relevant reactions of
these Family V enzymes are unknown, these studies illustrate that the ADC fold is a versatile
platform that can be adapted to perform different chemistries.
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CHAPTER I: INTRODUCTION
1.1 Biocatalysis
Biocatalysts are attractive tools for green chemistry because they are naturally regio-,
chemo-, and stereospecific, and have evolved to catalyze reactions under mild conditions in
aqueous solvent 7. Green chemistry aims to reduce or eliminate the creation or usage of
hazardous materials at all steps of chemical production, including reducing the environmental
impact from of chemical production processes 8. It also aims to reduce resource usage by
eliminating the need for high or low temperatures or pressures to facilitate catalysis. To date,
more than 100 biocatalysts have been used in industrial applications

9,

including the

pharmaceutical manufacture of Sitagliptin 10, a drug used in the treatment of Type II diabetes,
the production of high-fructose corn syrup 11, and environmental remediation, such as aromatic
hydrocarbon degradation 12. In addition, biocatalysts can be used in research or diagnostic roles
13.

Another advantage for biocatalysts is that for a good candidate, they have about 100 %

enantiomeric excess (ee) for chiral molecules. The choice of biocatalyst depends on a number of
factors, including whole cells or isolated enzymes, the chemistry, substrate specificity, catalytic
efficiency, and/or stability at various temperatures or in organic solvents

14.

The paradox for

enzymes in organic synthesis is that their specificity, their major strength, also limits their
usefulness, because it is difficult to find an enzyme to do the required chemistry with the desired
starting materials. This limitation can be overcome by engineering an existing enzyme to fit a
specific reaction, or by finding new enzymes with different activity or substrate specificity
profiles.
1

Finding the enzyme that catalyzes the desired reaction could obviate the need for enzyme
engineering. In many cases, it is possible to find homologs of known enzymes with improved
properties, such as altered substrate specificity, different stereochemistry of the product, altered
pH or temperature optima, increased activity, and/or increased temperature or solvent stability.
Genome mining has become an effective tool for identifying enzymes with potentially useful
catalytic activities. The amino acid sequence of an enzyme of interest can be used to find
homologous sequences in the database (e.g. the Basic Local Alignment Search Tool [BLAST]).
Detailed analysis of the resulting multiple sequence alignments can lead to identification of
differences in active site residues that may impact catalytic activity 15, 16. Nonetheless, functional
annotation in sequence databases is often incomplete or wrong

17.

The challenge remains to

make an educated guess on protein function from sequence information alone. More
information on potentially novel enzymes can be gleaned from sequence similarity networks
(SSNs) and the genome neighborhood network (GNN) 18, 19. Other large scale initiatives to mine
data range from protein-protein interactions 20, metabolic pathways 21, to databases specifically
for bacteria, archaea, and fungi 22. Once a new enzyme has been selected for study, it needs to
be expressed, purified, and tested for activity, substrate specificity, and stability. During or after
that process, the enzyme may need further engineering.

1.2 Protein Engineering
Protein engineering can proceed by three different methods, each with sub-techniques
for altering protein properties to meet process conditions: (1) rational design, (2) directed
evolution, and (3) computational design

13, 23.

2

First, rational design uses structural and

mechanistic information, as well as molecular modeling for prediction of changes in the protein
structure in order to change its properties 13. For instance, changing an active site Tyr to Phe by
studying an X-ray crystallographic structure by site directed mutagenesis uses rational design.
Next, directed evolution comprises of two major steps: random mutagenesis of the gene
encoding the enzyme, and identification of desired variants within the mutant library by
screening or selection 13. The most common means of generating the necessary genetic variation
are recombination-based methods (e.g. gene shuffling) and error-prone PCR. In gene shuffling,
related genes are digested with Deoxyribonuclease I (DNase I) and reassembled by polymerase
chain reaction (PCR) 24. This technique may take place in vitro or in vivo and relies on annealing
of homologous sequences on separate fragments of the gene 25. Error-prone PCR is another way
to achieve random mutagenesis in the hope of obtaining a protein variant with the desired
properties. This in vitro technique takes advantage of a DNA polymerase without proof-reading
ability, and/or manipulating the reaction conditions by adding divalent manganese or magnesium
during PCR amplification of a gene, or unbalancing nucleotide concentrations

26, 27.

All of these

manipulations cause the polymerase to make far more mistakes than it would under optimal
conditions. Site-directed saturation mutagenesis (SSM) combines elements of directed evolution
with rational design. Rational design targets specific residues with potential roles in catalysis,
substrate binding, or release. SSM samples all 20 of the proteinogenic amino acids at a limited
number of positions that are identified in structural and/or enzyme kinetic studies of the parent
enzyme. Lastly, computational tools like the HotSpot Wizard 13 also aid in the semi-rational design
process. This computational algorithm takes into account the protein structure, hypothetically
mutating residues in the active site or those lining access tunnels, hence “hot spots”, that the
3

user may choose to alter by site-directed mutagenesis 23, 28. In the case where an experimental
structure of a protein is not available in the Protein Data Bank (PDB), a homology model can be
made. This takes the sequence of the protein of interest, combined with a known structure of a
homologous protein with significant sequence identity 29. The backbone template with desired
sequence can be used as a guide for making amino acid mutations. A recent publication has made
the push for homology modeling and molecular docking together, which could greatly impact the
residues to be mutated 30.
Directed evolution and SSM can generate huge libraries, on the order of 106 ‒ 109 variants,
all of which must be assayed for the property being optimized 31. Thus, the primary limitation in
directed evolution experiments is the identification of mutants with desirable properties

32.

A

200 amino acid protein with two amino acid substitutions anywhere in the sequence generates
7,183,900 possible variants, three mutations in the same protein produces 9,008,610,600
possibilities

33.

All variants can be screened, or a partial library can be analyzed, with further

evolution done on the best mutants from the first library. High-throughput methods are
necessary in order to resolve the mutants in a timely manner. Fluorescence-activated cell sorting
(FACS) can monitor changes in substrate specificity and stereochemistry in a few hours, with up
to 108 variants

34.

This method can be coupled to cell surface display, in vitro

compartmentalization (IVC), or single cell compartmentalization 34. An in vivo selection method
with FACS has also been described, by coupling an enantiomer to both a specific carbon source
needed for growth and a toxic compound as a growth inhibitor to eliminate null mutation

35.

A

limitation of these approaches is that they are not run under realistic conditions; when subject
to physiological conditions or substrates, the hits from FACS may not perform as expected 31. Two
4

recent papers have found a way around this, yet still incorporating fluorescence. Chen et al.
developed microcapillary single-cell analysis and laser extraction (µSCALE), which begins with
variant libraries expressed in bacteria (Escherichia coli) or yeast (Saccharomyces cerevisiae) 36.
The method sorted single cells into a microcapillary, and fluorescence microscopy is used on the
microcapillary array. The microscope can detect emitting antibodies bound on the surface of a
yeast cell, fluorescent proteins in E. coli cells, or real-time kinetic measurements of enzyme
activity when the enzyme is bound to the surface of S. cerevisiae (provided the reaction produces
a fluorescent product 36). The hits can be retrieved by a precise laser extraction system 31, 36. Colin
et al. used a metagenomic library of 1.25 x 106 variants, pooled from different sources, and
expressed in E. coli with hopes of identifying promiscuous enzyme activity

37.

Single bacterial

cells were encapsulated into picoliter water-in-oil droplets, each presumed to contain one
bacterial cell with a different library member, and incubated with substrate and lysis agents. After
single cell lysis, the emulsion droplet was re-inserted into a microfluidic sorting chip, and diverted
based on fluorescence intensity of a leaving group 31, 37.
Semi-rational design principles discussed were applied by Pavlova et al. to develop an
enzyme to break down the recalcitrant toxin 1,2,3-trichloropropane (TCP) 38. TCP is a byproduct
in the manufacture of chlorinated compounds, it is used as a solvent, a component of paint and
varnish remover, and is proposed to be a human carcinogen

39.

TCP can be converted to 2,3-

dichloropropane-1-ol (DCL) by the haloalkane dehalogenase DhaA from Rhodococcus
rhodochrous, though the rate of this reaction is too modest to support a viable remediation
process. Random acceleration molecular dynamics (RAMD) was applied to the X-ray
crystallographic structure of WT DhaA from R. rhodochrous to simulate the release of product,
5

the rate-limiting step, from the enzyme active site 38, 40. This simulation highlighted residues that
might affect the movement of substrate and product through the access tunnels that connect
the buried active site to bulk solvent to enhance conversion of TCP. Previously, two residues were
found to increase activity 3-4 times by DNA shuffling and error-prone PCR

41.

Pavlova et al.,

however, focused on further enhancement of TCP to DCL conversion with updated methods,
including SSM to vary the nucleotide codon by more than one base pair at a time to create larger
screening libraries. The two previous mutants were starting points for directed evolution. More
than 5,000 clones were picked, grown, and assayed for TCP conversion using a high throughput
colorimetric assay based on phenol red, a pH-sensitive dye. The vast majority of DhaA variants,
96%, showed little to no improvement over WT. However, 25 clones with greater activity than
WT were ultimately sequenced and found to have unique mutations. The steady state kinetics
were monitored at 460 nm by mercuric thiocyanate and ferric ammonium sulfate, a more
sensitive assay than phenol red. In the end, five mutants were generated by site-directed
mutagenesis in the access tunnel to the active site. These mutations hindered water from getting
to the active site as suggested by RAMD, yet increased affinity for TCP, and increased kcat 32-fold
and kcat/KM 26-fold over the WT values. This study illustrates the utility of generating large mutant
libraries combined with high-throughput screening for protein engineering.
Semi-rational protein engineering and design has gained traction over the large
combinatorial libraries of directed evolution

42.

Semi-rational approaches can harbor smaller,

functionally rich libraries of variants, and reduce the reliance on high-throughput screening.
De novo design is the last method currently used to engineer enzymes, but it may be the
most difficult method to execute. First, a chemically plausible transition state for the desired
6

reaction is designed, then an active site that stabilizes that transition state is erected around it
by quantum mechanics/molecular mechanics (QM/MM) calculations

23, 43.

That transition state

and active site are then put into an existing protein scaffold and designed using a protein
modelling software package such as ROSETTA

44, 45.

This in silico/in vitro technique requires

Figure 1. Enzymes have been engineered to perform the Kemp elimination (A) 1, Diels-Alder reaction (B) 3, retro-aldol
cleavage (C) 4. Both the Kemp and Diels-Alder reactions are not found in nature.

7

structural information and is most useful for designing enzymes specifically for reactions found
not to occur in nature to aid in synthetic organic chemistry. Examples of in silico-designed
proteins have been more encouraging in recent years, though kinetic rates are still much slower
than natural enzymes 46. Directed evolution performed after the de novo design has been found
to drastically improve activity 44. Notably, the Baker laboratory has engineered enzymes in this
way to perform the non-natural (i.e. not found in biological systems) reactions shown in Figure
1. These include the Kemp elimination (A), the Diels-Alder reaction (B), and retro-aldol cleavage
(C) 1, 3, 4. They were first to tackle the challenge a multistep reaction with a non-natural substrate
4.

Retro-aldol cleavage has been described as the most difficult designed enzyme to date due to

its multistep reaction. Multistep reactions are more difficult to engineer, since multiple transition
states and intermediates must be considered simultaneously in the design of a composite
transition state in order for the reaction to occur 47-49.
Three considerations were given priority for the in silico design of retro-aldol cleavage,
borrowing themes from naturally occurring Type I aldolases: a hydrophobic pocket to lower the
pKa of the catalytic lysine, proton transfer from an ordered water molecule, and substrate binding
interactions 47. The three major protein scaffolds used were the jelly roll (PDB ID 1f5j), nuclear
transport factor 2 (NTF2) (PDB ID 1oho), and triosephosphate isomerase (TIM) barrel (PDB ID
1lbl) folds. Various positions within the active site were tested for the catalytic lysine to optimize
the Schiff base chemistry. Rational design was first done to residues in the active site to study
the relationship between sequence and activity. Surface residues were next altered to improve
solubility. Once an apparent optimum had been reached as determined by steady state kinetics,
directed evolution was done. Error prone PCR and DNA shuffling resulted in variants with
8

improved activity. In the improved variants, the mutations were found typically throughout the
protein. The most successful mutant was a TIM barrel that acquired 11 overall amino acid
changes concentrated largely in the active site, with a few occurring on the surface. Second shell
and buried residues were also changed. It is proposed that these mutations led to a different
conformation of an active site loop, as supported by lower B-factors, in the crystallographic
structure compared to earlier models

48.

A B-factor is a measurement related to the atomic

displacement of an atom from its average position 50. Overall, the information gleaned from this
study was the need for a flexible protein backbone rather than a rigid structure, and supporting
functional groups throughout the protein to increase activity.
The information gained from protein engineering can be applied to interpretation of
other work and facilitate understanding enzymes as a whole. Subtle changes of a significant
residue in a protein sequence can change protein activity, binding, and/or stability. Instances
throughout history can tell the story of biocatalysts before directed evolution or de novo work
were considered.

1.3 Acetoacetate Decarboxylase
Clostridium acetobutylicum is one of the first examples of an industrial, whole cell
biocatalyst, that later became well-studied for its specific contributions to acetone, butanol, and
ethanol production. It was in 1905 that acetone was discovered as a product of microbial
fermentation by Schardinger, and in 1913 Chaim Weizmann discovered the anaerobic bacterium
that would be named C. acetobutylicum

51.

Weizmann began producing acetone and butanol

from potatoes on an industrial scale in Britain, though the microbe could accept other starchy
9

substances, as well as glucose. Despite the small initial industrial process for acetone, it was not
enough to supply the British war effort at the advent of World War I in 1914. The British Navy, of
which Winston Churchill was a high ranking officer, heard about Weizmann and encouraged him
to develop large-scale industrial acetone production. Acetone was needed to produce cordite, or
smokeless gunpowder, for British munitions manufacture. Throughout World War I, the
Weizmann process, the production of acetone, butanol, and ethanol (ABE fermenation), used C.
acetobutylicum fermentation with maize as the original industrial starting material 52. The ABE
process was the industrial norm until the late 1940s, when more efficient and cheaper
petroleum-based methods were developed 51. Since green chemistry has been a larger concern
in recent years, there is renewed interest in C. acetobutylicum for its use in production of biofuels
53.

There continued to be an interest in one specific enzyme that aided in the transformation
of starch to acetone, acetoacetate decarboxylase (ADC). ADC is involved in solventogenesis,
which begins as cell growth slows down and transitions from classical sugar fermentation to
solvent production (acetone, butanol, and ethanol)

54.

In the 1960s-70s, Frank Westheimer

pioneered the application of physical organic chemistry principles to the study of enzymes, using
ADC as a model. He found that the reaction took place via a Schiff base mechanism

55.

Westheimer used a nitrophenol reporter group to propose that a perturbed pK a of an active site
lysine was responsible for the cleavage of acetoacetate to acetone and carbon dioxide. Without
a structure of the enzyme, he suggested the perturbed pKa was due to the electrostatic
interaction of an adjacent base, lysine side chain (K116), shifted the pK a of the active site lysine
(K115), from about 10 to about 6 56-58. Another study, from Highbarger et al., supported that K115
10

was the catalytic residue by chemical rescue of the active site K115 and adjacent K116 59. Residue
115 was changed to a cysteine while K116 remained, and at pH 6.0, the optimum of WT ADC, no
cleavage occurred for acetoacetate. However, activity was restored by aminoethylation of the of
the mutated C115 residue, which is very nearly the same size as the original lysine residue. In
addition, K116 was mutated to arginine, while K115 remained; the activity for K116R was lower
than WT, however the pKa for K115 was similar to WT, presumably due to the proximity of the
protonated arginine. Likewise, when K116C was alkylated with 2-bromoethylammonium
bromide, activity was restored and the pKa of K115 matched that of WT 59, 60. Westheimer passed
away in 2007, two years before the structures of acetoacetate decarboxylase from C.
acetobutylicum (CaADC) and Chromobacterium violaceum (CvADC) were solved 5. These
crystallographic models showed that the perturbed pKa of K115 was due to the hydrophobic
microenvironment, and not due to the electrostatics of the active site lysine and another
protonated base, K116, next to it, as illustrated in Figure 2 6. The largely hydrophobic active site

11

of acetoacetate decarboxylase destabilizes the protonated amine, leading to the effect observed
by the nitrophenol reporter group.

1.4 Acetoacetate Decarboxylase-Like Superfamily
Nature is a master of doing more, with less. Enzymes are no exception, as a relatively
small number of protein folds have been adapted to perform the myriad chemical reactions
occurring in living organisms

61.

It is possible to find numerous examples of putative or

hypothetical enzymes in the genome sequence databases, and it is often assumed that the
functions of so-called hypothetical proteins will match those of the closest homologs of known

Figure 2. Schematic representation of Westheimer’s electrostatic pKa perturbation hypothesis (A). The red
arrows represent electrostatic repulsion, and the blue arrows indicate electrostatic attraction. The 2009
structurally supported hydrophobic environment illustrates the proximity of Arg29 to orient the carboxylate
group in plane with the subsequent imine (B) 5, 6.

function. However, the versatility of enzyme scaffolds means that these assumptions are often
wrong

17,

especially when the level of sequence identity falls below 40 percent

12

62.

The

acetoacetate decarboxylase-like superfamily (ADCSF; IPR010451, IPR023375, and IPR023653) is
a prime example of this 2. This superfamily contains about 2,000 enzymes, which were all
assumed to catalyze the cleavage of acetoacetate to acetone and carbon dioxide. Although this
conversion does appear to dominate the superfamily, it has been shown that there is significant
chemical diversity within the ADCSF

2, 63.

There are too many sequences in even a small

superfamily like the ADCSF to clearly see the relationships between them, so protein sequence
similarity networks (SSN) were designed to visualize these large protein sequence data sets 18.
The aim of the Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST) is to separate
superfamilies into isofunctional clusters based on overall sequence similarity, and to shed light
on uncharacterized enzymes by observing their positions relative to well characterized ones.
SSNs are determined via BLAST scores; they are more visually impactful than dendrograms and
trees, which need computationally intense work for rigorous sequence alignments for large
groups of sequences. The sequence similarity network for the ADCSF calculated at e = 10 -10 is

Figure 3. Sequence similarity network for ADCSF calculated with an e value cutoff of 10-10. The clusters are based on manual
investigation of active site residues of a limited number of active site sequences.
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shown in Figure 3. The sizes of the nodes (red dots) reflect sequence length, and the edges (lines
connecting the nodes) are colored according to sequence identity, with red corresponding to 0
percent identity, and purple to 100 percent. All of the sequences from Family V are more similar
to each other than any other sequences in the diagram of Figure 3.
The first Family V
enzyme to be studied was
Mannopeptimycin

R

(MppR), an enzyme involved
in the biosynthesis of the
non-proteinogenic

Figure 4. The role of MppR in L-Enduricididine production.

amino

acid L-enduracididine, a necessary component of the antibiotics mannopeptimycin and
enduracidin, both of which are effective against methicillin resistant staphylococcus aureus
(MRSA).

Figure 5. Aldolase-dehydratase reaction catalyzed by MppR.
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MppR

from

S.

hygroscopicus (ShMppR)
was observed in X-ray
diﬀraction

experiments

to catalyze the cyclization
of

2-oxo-4-hydroxy-5-

guanidinovaleric acid (i.e.,
Figure 6. The quaternary structure comparison of MppR (Family V) and CaADC (Family
I). PDB IDs are 4JM32 and 3BH25, respectively.

“4-hydroxy-

ketoarginine”) to give what would become, after hydrolysis from the enzyme, the keto form of
the nonproteinogenic amino acid enduracididine, (Figure 4) 2. MppR is proposed to take a highly
oxidized arginine derivative and dehydrate the gamma hydroxyl to a double bond, before
catalyzing the attack of a guanidinium nitrogen
on the gamma carbon, to give the final
iminoimidizolidine ring product (Figure 4) 2.
However, it can also catalyze the aldol
condensation of pyruvate and imidazole-4carboxaldehyde, (Figure 5). ShMppR functions
via a mechanism that includes a Schiff base
intermediate. This is similar to the Type I
aldolases, which also use a lysine Schiff base in
their mechanisms. Interestingly, all known
Type I aldolases possess the TIM barrel fold. It
15

Figure 7. The fold of MppR is almost identical to that of
ADC, rather than the TIM barrel fold, associated with Type
I aldolases.

is not known if whether this is just the way evolution occurred, or if there is something unique
about the TIM barrel that suits it for the aldolase reaction.
Although MppR is a tetramer and ADC is a homododecamer, there does not appear to be
any functional significance to the quaternary structure. Despite the MppR protomer being almost
identical to ADC, MppR does not perform any decarboxylation like that of typical ADCs 2. Subtle
differences in the active site are responsible for this. The adjacent glutamate in the active site,
responsible for decarboxylase activity in CvADC 5, has been replaced with valine in MppR 2. In
addition, the arginine responsible for orienting the carboxylate group of acetoacetate in CvADC
is occupied by the indole ring of tryptophan in MppR.

Figure 8. Sequence alignment excerpt comparing Family I and Family V (shaded blue).
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Two hydrophobic residues in the active site of CvADC are polar in MppR, making a carboxylate
subsite to bind α-keto acids (Figures 4 and 5).
An examination of multiple sequence alignments aids in explaining these differences in
catalytic ability. The RxxxQ/N motif in Family V is not found in the Family I decarboxylases, and
may indicate other members of the family. There are two key residues conserved between the
two families, the lysine-glutamate catalytic dyad. The active site lysine and the likely glutamate
acid/base catalyst are highlighted in purple in Figure 8. They are within hydrogen bonding
distance of each other in the active site. Although this pair of residues and others are conserved,
the residues responsible for decarboxylation are not retained in Family V. The arginine in Family
I that aids in orienting the acetoacetate for nucleophilic attack (red box) is not conserved in
Family V. Likewise, the glutamate that facilitates decarboxylation in Family I (red box) has
different residues in Family V. The differences in these two key decarboxylase residues explains
why MppR is not a decarboxylase, though the conservation of the active site lysine and glutamate
hints that activity may still occur through a Schiff base mechanism.
Family V of the ADCSF is comprised of enzymes predicted to be involved in secondary
metabolism, including the biosynthesis of antibiotics and the catabolism of aromatic
hydrocarbons. To learn more about the diversity of chemistries performed in this family, we have
been studying Sbi_00515 from Streptomyces bingchenggensis (SbAD) and Swit_4259 from
Sphingomonas wittichii (Swit). Kinetic analyses of these enzymes demonstrate that neither
decarboxylates acetoacetate or similar compounds. X-ray crystallography revealed that, although
the quaternary structures are different, the overall folds of Sbi_00515 and Swit_4259 are almost
indistinguishable from that of ADC, like with MppR.
17

Sbi_00515 catalyzes the aldol condensation and subsequent dehydration of pyruvate with
a variety of aldehydes. It is quite specific for pyruvate, but reacts with a surprising number of
unsaturated, aliphatic and aromatic aldehydes. I performed the protein purification, site-directed
mutagenesis, and both steady state and transient kinetics on Sbi_00515 in order to determine
the substrate specificity profile and develop a plausible mechanism. The kinetic work was
supported by my X-ray crystallography, HPLC, and NMR work. I also performed single turnover
kinetics and kinetic isotope effect experiments to further develop our initial mechanistic
hypothesis. As it stands, our mechanism has the enzyme reacting with pyruvate to form a Schiff
base, after which the nucleophilic enamine attacks the aldehyde’s electrophilic carbonyl to form
a new carbon-carbon bond. Details of the dehydration step are still unclear, but may involve
substrate-assisted catalysis. The Schiff base with product is hydrolyzed to regenerate the enzyme.
Although the biological function of Sbi_00515 is unknown, it may synthesize a non-canonical
starter or extender unit of a nearby uncharacterized secondary metabolite biosynthesis cluster.
Streptomyces bingchenggensis, the organism that produces Sbi_00515, is not available.
Fortunately, there is a homolog from Burkholderia terrae, WQE_44883 (85% sequence identity),
which will be used to investigate the enzyme’s physiological role. The first step in this endeavor
is to find the growth conditions under which the gene is expressed. Metabolomics experiments
in the Shimazdu Lab for Advanced and Applied Analytical Chemistry at University of WIMilwaukee may then be able to highlight molecules that are only produced when Sbi_00515 is
expressed.
Swit_4259 is able to catalyze the aldol condensation with pyruvate and a limited range of
aldehyde substrates, however it is orders of magnitude slower than Sbi_00515. It is much more
18

efficient catalyzing the hydration of unsaturated α-keto acids without retro-aldol cleavage. Its
physiological function is also unknown, however, based on gene context, Swit_4259 is proposed
to contribute to the degradation of aromatic hydrocarbons.
All of my work shows that Sbi_00515 and Swit_4259 are the first Schiff base forming
aldolases that do not possess a TIM barrel fold. Although the tertiary structures are almost
identical, these two enzymes exhibit different activities, likely due to subtle changes in the active
site architecture. The significance of these enzymes is that they are the first evidence that the
ADC fold is a versatile platform that can be adapted to perform different chemistries, expanding
the knowledge of protein catalysis, and making these enzymes potential candidates for future
protein engineering experiments.
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CHAPTER II: STRUCTURAL CHARACTERIZATION OF SbAD
2.1: Introduction
Analysis of MppR (mannopeptimycin R) from the acetoacetate decarboxylase-like
superfamily (ADCSF) gave the first indication that this superfamily may contain enzymes that
catalyze diverse reactions, and as such, is a potential source of useful biocatalysts 1. Based on
gene context, it is proposed that the MppR-like enzymes, Family V of the ADCSF, are involved in
production of secondary metabolites. A BLAST search with MppR sequence returned a protein
from a bacterial genome noted for its secondary metabolites: Sbi_00515 from Streptomyces
binchenggensis BCW-1. The Gram-positive S. bingchenggensis has one of the largest genomes
sequenced to date at about 12 million bp 2. Much of the S. bingchenggensis genome is devoted
to production of secondary metabolites. S. bingchenggensis contains at least 47 gene clusters
linked to biosynthesis of identified or anticipated secondary metabolites 3. These include
milbemycins A3 and A4 that are used extensively to control parasitic worms in animals, 10
additional milbemycin analogues, the polyether antibiotic nanchangmycin, the antitumor agents
bingchamide A and B, and at least 23 uncharacterized nonribosomal peptide, polyketide, or
terpene biosynthetic clusters

2-8.

Sbi_00515 is currently annotated as an acetoacetate

decarboxylase, yet like MppR, it is missing the same key arginine and glutamate residues
responsible for decarboxylase activity in the ADCs, and is located near an uncharacterized
polyketide biosynthetic cluster 2.
Sbi_00515 has 39% sequence identity to MppR from Streptomyces hygroscopicus
(ShMppR), and 265 amino acids 9. Based on sequence alignment to ShMppR, Sbi_00515 is likely
26

to have the same carboxylate binding site and lack of decarboxylase activity. Although both
Family V enzymes retain the key lysine and likely acid/base catalyst glutamate that can form a
Schiff base intermediate, it is possible that Sbi_00515 may not act in the same manner as MppR.
Sequence alignment comparing the active site residues of MppR with Sbi_00515 shows that in
two positions where MppR has Phe, Sbi_00515 has Tyr, and Glu in MppR is replaced with another
Tyr in Sbi_00515. The change in residues of the likely active site of Sbi_00515 could influence
substrate specificity or reaction(s) catalyzed. The S. bingchenggensis bacterium is not available
for biological study due to intellectual property concerns, therefore its physiological activity will
likely never be known. Therefore, the purpose of this study was to investigate the catalytic
capacity of the MppR-like family specifically, and the ADCSF in general.

2.2 Materials and Methods
Cloning, Expression, and Purification of Sbi_00515.
The coding sequence of Sbi_00515 was optimized for expression in Escherichia coli and
synthesized by GenScript Inc. (Piscataway, NJ). This synthetic gene was subcloned into the pESUMOkan expression vector (LifeSensors Inc., Malvern, PA) using primers containing BsaI and XbaI
restriction sites (forward, 5′-GGTCTCAAGGTATGAAAGGTTATACGGTTCCG-3′; reverse, 5′GCTCTAGATCATCATGCCGAATGGTCTGC-3′). The His6-tagged SUMO−Sbi00515 fusion protein was
expressed from E. coli BL21 Star (DE3) cells (Invitrogen Inc., Carlsbad, CA) carrying the pE-SUMOSbi_00515 plasmid. Cultures were grown in Luria-Bertani medium with 50 μg/mL kanamycin at
37 °C. At an OD600 of about 0.9, protein expression was induced with 0.4mM IPTG. The
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temperature was reduced to 25 °C, and the cultures were grown overnight while being shaken at
250 rpm. Cells were harvested by centrifugation at 13000 x g, resuspended in 5 mL/g of buffer A
[25 mM Tris (pH 8.0), 300 mM NaCl, and 10 mM imidazole] supplemented with 1 mg/mL hen egg
lysozyme (Hampton Research) and frozen at −20 °C. Cells were lysed by thawing the resuspended
cells for 2 hours at room temperature (RT), after which DNase I (Worthington Biochemical Corp.,
Lake-wood, NJ) was added to achieve a concentration of 0.1 mg/ml. The lysate was clarified by
centrifugation at 39000 x g for 45 min and then applied to a 5 mL HisTrap column (GE
Lifesciences,Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6-SUMO−Sbi_00515
fusion protein. The protein was eluted by a four-step gradient of buffer B [25 mM Tris (pH 8.0),
300 mM NaCl, and 250 mM imidazole (5, 15, 50, and 100%)]. The His6-SUMO−Sbi_00515 fusion
protein eluted in the third and fourth steps and was ∼90% pure, as judged on Coomassie-stained
sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS-PAGE) gels. Peak fractions were
pooled and dialyzed overnight against 3.5 L of 25 mM Tris (pH 8.0) and 150 mM NaCl in the
presence of about 3 μM SUMOprotease (LifeSensors Inc.). The dialysate was passed through the
HisTrap column a second time to remove the cleaved His6-SUMO tag as well as the protease. The
resulting Sbi_00515 preparation was >95% pure. Selenomethionine-labed Sbi_00515 was
purified using the same protocol, except that SelenoMethionine Medium Complete (Molecular
Dimensions, Newmarket, Suffolk, U.K.) was used as the growth medium rather than Luria-Bertani
broth and T7 Express Crystal cells (New England Biolabs, Ipswich, MA) were used in place of the
BL21 Star (DE3) cells.
Crystallization, Structure Determination, and Model Refinement.
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Initial crystallization conditions were identified by screening 45 mg/mL Sbi_00515 against
the Index HT screen (Hampton Research). After optimization, diffraction-quality crystals were
obtained by the hanging drop vapor diffusion method from 3.5−3.7 M potassium formate, 2−3%
polyethylene glycol monomethyl ether 2000 (PEG MME 2k), and 100 mM BIS-Tris propane (pH
9.0). Drops contained 1−2 μL of a protein solution at 45 mg/mL and 1 μL of a crystallization
solution. Crystals formed as plates that appeared after 3−4 days and grew to maximal dimensions
of about 800 μm × 200 μm × 50 μm. Crystals of selenomethionine (SeMet)-substituted Sbi_00515
were grown using the same conditions. Crystals were cryoprotected with Paratone N (Hampton
Research) and flashed-cooled by being plunged into liquid nitrogen. The structure of Sbi_00515
with pyruvate bound was obtained by transferring crystals of native Sbi00515 into 30 μL drops of
a soaking solution containing 4.0M potassium formate, 3% PEG MME 2k, 100 mM BIS-Tris
propane (pH 9.0), and 30 mM sodium pyruvate. After soaking overnight, crystals were treated
with Paratone N and flash-cooled. X-ray diffraction data for SeMet Sbi_00515 and a higherresolution native data set were collected at beamline 21-ID-D of the Life Science Collaborative
Access Team (LS-CAT) at the Advanced Photon Source (APS). The Sbi_00515·pyruvate data set
was collected using the rotating anode X-ray source at Marquette University. Data were
processed with HKL2000 or MOSFLM and SCALA of the CCP4 Program Suite 10-14. The structure of
Sbi_00515 was determined by the single-wavelength anomalous diffraction (SAD) method using
1.9 Å-resolution data collected from a crystal of SeMet-substituted Sbi_00515 at 0.97921 Å, 4.0
eV above the tabulated K-edge wavelength for Se (0.97950 Å). The program autoSHARP was used
to determine the Se substructure, which contained 16 of the 24 Se atoms in the asymmetric unit,
and to calculate density-modified electron density maps. An initial model comprising about 75%
29

of the asymmetric unit contents was built automatically using the PHENIX package
(phenix.autobuild) 15-17. After iterative cycles of manual model building in COOT and maximum
likelihood-based refinement using the PHENIX package (phenix.refine), ordered solvent
molecules were added automatically in phenix.refine and culled manually in COOT

18, 19.

Hydrogen atoms were added to the model using phenix.reduce and were included in the later
stages of refinement to improve the stereochemistry of the model 20. Positions of H atoms were
refined using the riding model with a global B factor. Regions of the model for translationlibration-screw (TLS) refinement were identified using phenix.find_tls_groups, and the TLS
parameters were refined in phenix.refine. Once the refinement converged (e.g., for SeMet
Sbi00515, R = 0.162 and Rfree = 0.185), the model was validated using the tools implemented in
COOT and PHENIX

21, 22.

Sections of the backbone with missing or uninterpretable electron

density were not included in the final model. Side chains with poor or missing electron density
were modeled in favored rotameric conformations. The B factors were allowed to refine without
additional restraints, and the occupancies for atoms in all residues without alternate
conformations were constrained to be 1.0.
The final, refined model of SeMet Sbi_00515, stripped of water molecules and H atoms,
and with all B factors set to 20.0 Å2, was used to determine the structures of Sbi_00515
“unliganded” (with formate bound) and with pyruvate bound by the difference Fourier method.
A similar refinement protocol was used for both models presented here. In the case of the
Sbi_00515·pyruvate structure, restraints for the link between Lys122 and pyruvate were
generated with phenix.elbow

23.

Data collection and model refinement statistics are listed in

30

Table 2.1. Coordinates and structure factors have been deposited in the Protein Data Bank as
entries 4ZBO and 4ZBT.

2.3 Results and Discussion
Overall Structure and Comparisons to CaADC and ShMppR.
Figure 9. (A) Rendering of the
solvent-accessible
surface
of
Sbi00515 showing the extensive
tetramer interface formed by the
long, interdigitating loops (top). This
interface is repeated on the back
side with the orange and pale yellow
protomers. The pair of dimers is held
together (bottom) by short loops
that appear to “clip” the two dimers
together to form the tetramer. (B)
The ribbon diagram showing a single
protomer is oriented like the dark
blue protomer in panel A. The main
barrel of the β-cone fold is colored
pale blue, with the “side barrel”
colored green. The dimer interface
loops are colored yellow, and the
loops forming the interface between
the dimers are colored orange. The
section of the polypeptide that is
colored red is the “active site loop”
that may control access to the active
site. The catalytic Lys122 is shown as
a ball-and-stick representation with
purple carbon atoms.

Sbi_00515 has a protomer weight is 28,145 Da and, like MppR, was shown to be
tetrameric in solution using size exclusion chromatography. Sbi_00515 crystallized in space group
P21212 with four molecules in the asymmetric unit (unit cell dimensions a = 157.3Å, b = 123.5 Å,
c = 53.1 Å, and α = β = γ =90°). The asymmetric unit contents are arranged in a tetramer that
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matches closely the arrangement seen in ShMppR 1. This tetramer is a dimer of dimers (Figure 9
A). The “dimer interface” is extensive, being comprised of interdigitating loops (Met1−Pro21 and
Arg186−Glu203; yellow in Figure 9 B) that bury 2642 Å2, or 20% of the protomer surface area.
The interface between the dimers, which we call the “tetramer interface”, is smaller, burying
1621 Å2, or 12% of the protomer surface, and is also comprised of two surface loops (Ser68−Gln81
and Gln129−Gly164; orange in Figure 9 B). The homotetrameric quaternary structure shared by
Sbi_00515 and ShMppR is markedly different from that of CaADC, which is a homododecamer.
Table 1. Crystallographic Data Collection and Model Refinement Statistics.
SeMet Sbi_00515

native Sbi_00515

Sbi_00515·pyruvate

resolution (Å) (last shell)a

46.5−1.9 (1.97−1.90)

41.58−1.4 (1.45−1.40)

39.9−1.8 (1.86−1.80)

wavelength (Å)
no. of reﬂections
observed
unique
completeness (%)a
Rmerge (%)a,b
multiplicity
⟨I/σ(I)⟩a
ﬁgure of merit (acentric)
phasing power

0.97921

0.97896

1.54180

1131019 (96476)
1626413 (91229)
82988 (8183)
207128 (20393)
100.0 (100.0)
99.9 (99.5)
0.145 (0.456)
0.071 (0.560)
13.6 (11.8)
7.9 (4.5)
22.3 (5.9)
20.5 (2.2)
0.283
1.102
Model Refinement

285228 (8521)
92300 (6104)
95.4 (64.0)
0.102 (0.334)
3.1 (1.4)
12.3 (1.7)

no. of reﬂections in the work set
no. of reﬂections in the test set
Rcryst (Rfree)
no. of residues
no. of solvent atoms
no. of TLS groups
average B factor (Å2)c
protein atoms
ligand atoms
solvent
root-mean-square deviation
bond lengths (Å)
bond angles (deg)
coordinate error (Å)
Ramachandran statistics
(favored/allowed/outliers)

78722
4185
0.162 (0.185)
1023
1166
24

207021
2960
0.154 (0.176)
1034
1385
25

92221
4631
0.163 (0.205)
1028
1289
25

15.9
35.6
26.9

21.0
33.9
34.1

21.4
31.9
31.3

0.005
0.979
0.30

0.009
1.303
0.12

0.011
1.309
0.18

98.2/1.8/0

97.7/2.3/0

97.2/2.8/0

aValues
bR

in parentheses apply to the high-resolution shell indicated in the resolution row.
= ∑(||Fobs| − scale ×| Fcalc||)/∑|Fobs|. cIsotropic equivalent B factors, including the contribution from TLS reﬁnement.
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Figure 10. (A) Stereoview of the active site in the “unliganded” Sbi_00515 structure showing potassium formate from the
crystallization solution bound (refer to Figure 11 for relevant hydrogen bonding interactions and their distances). The position
of this formate ion shows that the carboxylate-binding site identified in S. hygroscopicus MppR is retained in Sbi_00515. The
lower water molecule in this view (labeled “1” in Figure 11) bridges Tyr82 and Glu84, suggesting that both residues could
participate in the Schiff base chemistry. The upper water molecule (“2” in Figure 11) is held in place by interactions with
Tyr252, which is the major difference between the Sbi_00515 and ShMppR active sites. (B) The Sbi_00515·pyruvate Schiff base
complex shows pyruvate covalently bound to the enzyme as indicated by continuous electron density between Lys122 and
the α-carbon of pyruvate. The side chain of pyruvate is too short to unequivocally differentiate between the imine and
enamine forms of the Schiff base. Note that water “1” has been displaced, water “2” remains in a similar position, and two
new water molecules have been recruited so that Glu84, Gln118, and Tyr252 are all linked by an extensive hydrogen bonding
network. In both panels, the experimental 2|Fo|−|Fc| electron density map (magenta) and the simulated annealing composite
omit 2|Fo| − |Fc| electron density map (green), both contoured at 1.0σ, are drawn with a 2.0 Å radius around each atom of
Lys122, formate or pyruvate, and select water molecules. This figure and subsequent figures showing crystallographic
structures were rendered with the POVSCRIPT+24 modification of MOLSCRIPT25 and POVRAY.
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In both Sbi_00515 and ShMppR, the trimerization platform of CaADC is occluded by the loops of
the tetramer interface. This pair of sequence insertions accounts for the difference in quaternary
structures between the classical ADCs and the MppR-like family. Thus far, there is no known
functional consequence of the quaternary structure in ADCSF enzymes.
The tertiary structure of Sbi_00515 is essentially identical to those of both MppR and
CaADC, with root-mean-square deviations (RMSDs) for all aligned Cα atoms of 1.4 and 1.7 Å,
respectively. This is not surprising, given that all ADCSF proteins of known structure {PDB entries
3BH2, 3BH326, 4JM31, 3C8W [Joint Center for Structural Genomics (JCSG), unpublished], and
3CMB (JCSG, unpublished)} share the same β-cone or double-barrel fold first identified by Ho et
al.26 (Figure 9 B). In spite of the remarkable similarity of the overall folds, the active sites of
Sbi_00515 and CaADC are different. Specifically, as in ShMppR, Arg29, the residue responsible

Figure 11. Schematic views of (A) the Sbi_00515·formate complex and (B) the Sbi_00515·pyruvate complex showing potential
hydrogen bonding interactions and their distances (in Angstroms).
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for orienting the substrate in CaADC, and Glu61, thought to electrostatically encourage the
carboxylate group of acetoacetate to leave as CO2, are missing in Sbi_00515. These two sequence
changes alone would account for the loss of acetoacetate decarboxylase activity in the MppRlike enzymes.
The other major difference between CaADC and the MppR-like enzymes is the presence
of the very polar “carboxylate-binding site” adjacent to the catalytic lysine residue (Lys122 in
Sbi_00515). This site is marked in the “unliganded” structure of Sbi_00515 by a bound formate
ion from the crystallization solution (Figures 10 A and 11 A). The ion is held by hydrogen bonding
interactions between O1 of formate and the hydroxyl group of Tyr24 (2.6 Å) or the guanidinium
group of Arg114 (2.7 Å), and between O2 of formate and the amide nitrogen atom of Gln118 (2.9
Å) or the amino group of Lys122 (2.7 Å). Two water molecules are also bound in close proximity
to the catalytic Lys122 and the bound formate ion. One, labeled “1” in Figure 11 A, is bridging
Tyr82 and Glu84 (equidistant at 2.7 Å), while the other, labeled “2,” is held by interactions to
water “1” (2.9 Å) and the hydroxyl group of Tyr252 (2.6 Å). The position of water molecule “1,”
only 3.3 Å from the amino group of Lys122, suggests that Tyr82 and Glu84 might both participate
in the Schiff base chemistry of Lys122.
The active site of Sbi_00515 is similar to ShMppR, however a few changes in residues
appears to alter the substrate specificity and reactivity of catalysis 1. In Sbi_00515, Tyr252
replaces the Glu283 of MppR that is thought to help orient the guanidinium group of a
hydroxylated arginine derivative for cyclization 1. In addition, Tyr82 is a phenylalanine residue in
MppR (Phe116), and Tyr24 of Sbi_00515 is also a phenylalanine in ShMppR (Phe58). All of the
other residues are identical (Figure 12 A). Tyr24 of Sbi_00515 is especially interesting, because it
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is a component of the carboxylate-binding site not present in ShMppR and alters the
conformation of the Schiff base complex between pyruvate and Lys122.

Schiff Base Complex with Pyruvate.
Crystals of Sbi_00515 were soaked in a solution containing 30 mM sodium pyruvate, and
the resulting covalent enamine/imine complex was trapped crystallographically (Figures 11 B and
12 B). The carboxylate moiety of pyruvate is bound in the carboxylate-binding site of the enzyme,
making hydrogen bonding interactions with the hydroxyl groups of Tyr24 and Tyr82 (2.6 and 3.2
Å, respectively) and the amide nitrogen atom of Gln118 (2.8 Å), as well as a potential salt bridge
with Arg114 (bidentate at 3.0 Å). Binding of pyruvate does not impact the positions of the side
chains comprising the carboxylate-binding site [Tyr24, Arg114, and Gln118 (Figure 12 A)],
indicating that this site is preconfigured to bind α-keto acids. This may explain why the Schiff base
complex is sufficiently stable to be observed in the crystal structure. The residues closer to the
catalytic center, Tyr82, Glu84, and Val106, experience small, but significant and concerted,
changes in their positions. Tyr82 swings toward the catalytic lysine, moving the hydroxyl group
by 0.6 Å, while Glu84 swings away from Lys122, shifting its carboxylate group by 1.4 Å. The
distance between the nearest carboxylate O atom of Glu84 and the pyruvate methyl group is 3.9
Å. Given this arrangement, it is plausible to suggest that Glu84 might act as a general base catalyst
to promote formation of the reactive enamine form of the Schiff base. Lastly, although it is some
distance from the Lys122-Glu84 dyad, Tyr252 also experiences a 0.6 Å shift of its hydroxyl group
toward Lys122, likely because of a rearrangement of the water structure around the catalytic
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Figure 12. (A) Stereoview showing the complex of Sbi00515 and formate (pale blue model with purple formate ion) overlaid
on the enzyme with pyruvate bound (dark blue model). Note the subtle changes in position that occur for residues Tyr82,
Glu84, and Tyr252, while the residues comprising the carboxylate-binding site are essentially unperturbed. (B) MppR·pyruvate
complex (green model) overlaid on the Sbi_00515·pyruvate complex (dark blue model). In spite of the high degree of structural
similarity (1.7 Å rmsd for all aligned Cα atoms), the arrangement of residues in the carboxylate-binding site is subtly different
because of the addition of Tyr24 in Sbi_00515. This change results in Sbi_00515 binding the pyruvate carboxylate with a
monodentate interaction with Arg114 and an additional hydrogen bonding interaction with Tyr24, which holds the carboxylate
in plane with the pyruvate methyl group (2.8 Å fromCH3 to carboxylate O). This change, coupled with the Glu→Tyr change at
position 283/252, may account, in part, for the difference in catalytic activity between Sbi_00515 and MppR.

center that occurs upon formation of the Schiff base (Figure 12 B). In the pyruvate-bound
structure, the water bridging Tyr82 and Glu84 is displaced (water “1” in Figure 11 A) and two
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additional water molecules are recruited (labeled “3” and “4” in Figure 12 B) that create a chain
connecting Glu84, Gln118, and Tyr252. The position of water molecule “2” moves along with
Tyr252 by 0.8 Å, placing it 3.6 Å from the pyruvate methyl group. The position of this water is
instructive, because when the incoming aldehyde substrate is placed so that the aldehyde O atom
overlays water “2” and the re face of the carbonyl faces the pyruvate methyl group, the distance
between the methyl and carbonyl carbons is approximately 3 Å.
It was somewhat surprising to find that although pyruvate occupies the same binding site
in Sbi_00515 and ShMppR, the conformations of the Schiff base complexes are different. In
ShMppR (PDB entry 4JMC), the pyruvate carboxylate group is nearly coplanar with the
guanidinium of Arg148, making a clear salt bridge interaction. In Sbi_00515, the substitution of
Tyr24 for Phe58 of ShMppR results in the carboxylate-binding site Arg and Gln residues taking
different conformations. As a result, the pyruvate carboxylate in the Sbi_00515·pyruvate
complex is rotated by about 30° relative to the ShMppR·pyruvate structure. The rotation of the
carboxylate weakens or eliminates the salt bridge to Arg114 and creates a new interaction with
Tyr24. This change also forces the carboxylate to nearly eclipse the methyl group (O2−C1−C2−C3
torsion angle of 14°). While it is possible that this nearly eclipsed conformation just happens to
be the lowest-energy conformation in this complex, the strain inherent in this arrangement, the
2.8 Å distance between the carboxylate oxygen and the methyl carbon, and the potential loss of
the salt bridge raise the possibility of substrate-assisted catalysis. It is possible that the
carboxylate could abstract a proton from the former pyruvate methyl carbon during the
transition from the presumed aldol intermediate to the unsaturated product. A substrate
carboxylate is proposed to act as a general acid/base catalyst in sialic acid aldolase 27. Sialic acid
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aldolase is specific for pyruvate, and aldol condensation occurs between pyruvate, which acts as
a proton donor and various aldehydes. The product of the condensation reaction is determined
by the aldehyde acceptor, as sialic acid aldolase appears to lack strict stereochemical specificity,
unlike most Type I aldolases 27, 28. Despite the pyruvate specificity and enzymatic reversibility, a
number of crystal structure illustrate that there are no acidic or basic residues near the reaction
center, leading to the hypothesis that substrate-assisted catalysis must occur, as seen in Figure
13.

27, 29, 30.

In addition to sialic acid aldolase, other enzymes are thought to function with

assistance from a substrate carboxylate as a general acid/base catalyst, such as trans-ohydroxybenzylidenepyruvate hydratase-aldolase and D-4-deoxy-5-oxoglucarate dehydratase 3133.

Figure 13. (A) Sialic acid proposed mechanism 27, 30.
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2.4 Conclusions
The structures of the enzyme in complexes with formate and pyruvate point out possible
roles of several active site amino acids. Both Tyr82 and Glu84 are near enough to the catalytic
lysine residue to make contacts with the presumed hemiaminal intermediate during formation
and breakdown of the Schiff base. Because only Glu84 is in a position to reach both Lys122 and
the methyl group of pyruvate, and Tyr82 is not absolutely conserved in MppR-like enzymes,
Glu84 is the most likely candidate for the general acid/base catalyst. The position of the water
molecule held by Y252 in the presence and absence of pyruvate implies that this residue might
orient the incoming aldehyde substrate for attack by the enamine nucleophile. Kinetic and
structural characterizations of said active site residues and others are mutated in the following
chapters to explore their effects on binding and catalysis.
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CHAPTER III: IDENTIFICATION OF THE REACTION CATALYZED
3.1 Introduction
Previous studies have shown that, while ADCSF enzymes appear to be structurally
homogeneous [e.g., CaADC (PDB entry 3BH2), Chromobacterium violaceum ADC (PDB entry
3BH3), Legionella pneumophila ADC (PDB entry 3C8W), Methanoculleus marisnigri ADC (PDB
entry 3CMB), Streptomyces hygroscopicus MppR (PDB entry 4JM3), and Sbi_00515 (PDB entry
4ZBO, this study)], there is some diversity in terms of the substrates used and the chemistry
catalyzed by members of this superfamily 1. MppR from S. hygroscopicus (ShMppR), for instance,
can catalyze the cyclization of 2-oxo-4-hydroxy-5-guanidinovaleric acid (“4-hydroxyketoarginine”) as observed by X-ray crystallography 1. After hydrolysis from the enzyme, the
compound is the keto form of the nonproteinogenic amino acid enduracididine. While the precise
role of ShMppR in the biosynthesis of enduracididine remains unclear, it is apparent that very
little is known about the degree of substrate and reaction diversity within the ADCSF.
Not surprisingly, the divergence of ShMppR and Sbi_00515’s catalytic activities from the
classical acetoacetate decarboxylases like CaADC is associated with a number of amino acid
substitutions in the active site. Chief among these are the loss of an Arg side chain proposed to
orient the substrate for decarboxylation in CaADC, loss of the “second Glu” side chain thought to
promote decarboxylation in CaADC, and an increase in polarity in the neighborhood of the
catalytic Lys in ShMppR and Sbi_00515

2, 3.

This latter change results in the formation of an α-

carboxylate-binding site 1. Comparative genome analysis of ShMppR and Sbi_00515 and closely
related homologues showed that there exists a subset of ADCSF enzymes that share this same
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pattern of amino acid substitutions in their putative active sites. These so-called MppR-like
enzymes comprise one of seven sequence clusters or families within the ADCSF (Family V, Figure
3).

Figure 14. Gene content of Sbi_00515, in red as 515. The bubbles are annotations from the NCBI database. Often in bacteria,
genes for a process are located near one another, with the Type I polyketide synthase (522/PKS2) in purple of primary interest.

Sbi_00515 was chosen for study on the basis of its sequence similarity to ShMppR (39%
sequence identity) and its gene context, which suggests a potential role in an uncharacterized
polyketide biosynthetic cluster (Figure 14).
It is predicted that the polyketide
biosynthetic cluster produces a compound
relevant as an anti-tumor compound, BE-

Figure 15. BE-14106, the predicted product of Type I polyketide
synthase (522/PKS2) of Figure 14.

14106 (Figure 15) 4. Attempts to obtain
samples of live cells or genomic DNA were unsuccessful because of intellectual property
concerns. As such, the precise biological function of Sbi_00515 cannot currently be veriﬁed.
Although Sbi_00515 and ShMppR have both been shown by X-ray crystallography to bind
pyruvate, the carboxylate group of pyruvate is bound in different conformations in each enzyme
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3.

Other subtle active site differences between ShMppR and Sbi_00515 result in different

positions for conserved waters. This hints that Sbi_00515 and ShMppR may not have the same
activities, despite the fact that both are expected to retain the Schiff base mechanism of
acetoacetate decarboxylase based on their active site residues.

3.2 Materials and Methods
Materials
Aldehyde substrates and sodium pyruvate were sourced from Sigma-Aldrich.
Cloning, Expression, and Purification of Sbi_00515.
The protein was previously cloned and expressed as described in Chapter II 3.
Preparation of Benzylidenepyruvate (1).
(E)-2-Oxo-4-phenylbut-3-enoicacid (Scheme 1, 1) was prepared by a modiﬁcation of the
technique of Reimer 5 . A suspension of benzaldehyde (5.22 g, 49.2 mmol), sodium pyruvate (5.42
g, 49.3 mmol), and KOH (1.41 g,25.2 mmol) in 15 mL of methanol and 15 mL of water was warmed
from < 10 to 35 °C and held at that temperature for 1.5 hours, over which time the starting
materials dissolved, and then the product crystallized. Filtration, rinsing with 50 mL of cold
methanol, and drying in vacuo gave 5.25 g of a yellow solid. A solution of 5.18 g of the yellow
solid in 150 mL of water was ﬁltered and acidiﬁed with HCl (2.0 M, 180 mL), and the resulting
precipitate was isolated by ﬁltration and then dried by addition and rotary evaporation of 50mL
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of toluene in vacuo to yield 2.91 g of product as an orange solid (34% yield). The 1H and 13C NMR
spectra of this product were identical to those reported previously 6.
Preparation of 3-(2-furyl)acrolenepyruvate (22).
6-(furan-2-yl)-2-oxohexa-3,5-dieneoate (Scheme 4, 22) synthesis began with 0.4243 g
(3.47 mmol) of 3-(furan-2-yl)acrylaldehyde was combined with 0.420 g (3.86 mmol) of sodium
pyruvate and 0.1300g (3.25 mmol) of sodium hydroxide in a dry round bottom flask. Once
combined, 50 mL of methanol was added to the reaction mixture and the flask was attached to
a reflux condenser, then flushed with nitrogen. The reaction mixture was allowed to reflux for 23
hours, at which point TLC had indicated the total consumption of the starting aldehyde and the
reflux was stopped. The reaction mixture was allowed to cool to room temperature then chilled
to precipitate the product. The precipitate was filtered and the filtrate acidified by bubbling CO2
through until a pH of 8.0 was attained. The filtrate was concentrated via rotary evaporation, dried
in a desiccator for multiple days and combined with the precipitate afforded 0.8824 g of a bright
yellow solid (124%).
The product was placed into an Erlenmeyer flask where upon 20 mL of dichloromethane,
4 mL of trimethylamine and 8 mL of distilled H2O was added. With stirring, CO2 was bubbled
through the mixture until the trimethylamine and aqueous phases became homogenous. This
was transferred to a separatory funnel and the product was further extracted by two more 20
mL additions of dichloromethane. The organic phases were combined, dried over MgSO 4 and
concentrated by rotary evaporation to afford a dark amber oil. Once dried, the sodium salt was
formed by suspending the oil in ethyl acetate and first washing with 1 M HCl until the organic
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phase indicated a pH of 2.0. The organic layer was then separated and a 1 M methanolic solution
of sodium hydroxide was added until a pH of 8.0 was attained. This was then concentrated by
rotary evaporation and dried in a desiccator for two days to afford 0.5430 g (69% isolated) of the
sodium salt verified by ESI-LCMS and 1H NMR.
Preparation of cinnamylidenepyruvate (23).
Potassium (3E,5E)-2-oxo-6-phenylhexa-3,5-dienoate (Scheme 4, 23) was preparped from
3.292 g (24.91 mmol) cinnamaldehyde, 2.804 g (25.48 mmol) sodium pyruvate, and 0.1123 g
(2.808 mmol) NaOH were combined with 25 mL CH3OH before being placed under an atmosphere
of N2 and heated to reflux for 17 h. The volume was observed to be heterogeneous with yellow
solid, but TLC showed that the starting aldehyde was still present (25% CH3CN/CH2Cl2 Rf: 0.85)
and concentrated to dryness with rotary evaporation. 0.4030 g (10.08 mmol) NaOH and 46 mL
CH3OH were placed into the reaction vessel and heated at reflux for 3 h before the starting
aldehyde was no longer visible by TLC. The yellow solid was collected by vacuum filtration, rinsed
with two 100 mL portions CH3OH, and placed under vacuum overnight to afford 2.083 g (37%
crude yield). CO2 was bubbled into the filtrate until it reached pH 8.0 before being concentrated
to dryness with rotary evaporation before being combined with 150 mL 18Ω H 2O and 75mL
triethylamine (TEA). CO2 was bubbled into the mixture while on ice until it became homogeneous
before being extracted with five 50 mL CH2Cl2. The organic portions were combined, dried over
MgSO4, filtered, concentrated with rotary evaporation, and placed under vacuum overnight to
yield 2.050 g of an auburn oil. The oil was combined with 100 mL EtOAc, heated to boiling,
decanted from the remaining undissolved semisolid, and cooled to room temperature. The
supernatant was combined with 1.643 g (9.013 mmol) potassium 2-ethylhexanoate (K-2EHA)
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dissolved in 30 mL EtOAc which produced a precipitate. The solid was collected by centrifugation,
washed with two 30 mL portions EtOAc, and placed under vacuum overnight to remove residual
solvent to afford 0.433 g of crude cinnamylidenepyruvate as a yellow solid. Initially, 2.045 g of
the isolated yellow solid was dissolved in 185 mL 2.4 M triethylammonium bicarbonate (TEABC)
and extracted with four 50 mL portions CH2Cl2. The organic extracts were combined, dried over
MgSO4, filtered, concentrated with rotary evaporation, and placed under vacuum overnight to
yield 1.0963 g of an auburn oil. The oil was combined with 50 mL EtOAc and stirred at room
temperature before the supernatant was decanted and mixed with 0.8073 g (4.429 mmol) K2EHA producing a solid upon mixing. The solid was collected by centrifugation, washed with three
30 mL portions EtOAc, and dried under vacuum to afford 0.7836 g of crude
cinnamylidenepyruvate as a yellow solid. Cinnamylidenepyruvate was crude at 1.118 g, was
recrystallized from 55 mL CH3OH and 100 mL EtOAc, boiled down to 1/3 of the total volume, and
stored in a -10 ˚C freezer overnight. The resulting solid was collected by centrifugation and dried
under vacuum to yield 0.914 g cinnamylidenepyruvate, as a yellow solid (15% yield, 99.4%
cinnamylidenepyruvate, 0.6% by mass pyruvate, mp = 204 ˚C (darkens to tan), 228 ˚C (shrinks,
darkens to brown).
1H

NMR (300MHz, D2O): δ7.63 (d, J=8.1Hz, 2H); 7.51 (qAB, J=15.6Hz, 9.6Hz, 1H); 7.48-7.41(m, 3H);

7.20-7.07 (m, J=15.6Hz; 8.7Hz, 2H); 6.40 (d, J=15.6Hz, 1H)
13C

NMR (300MHz, D2O): δ198.3; 173.0; 151.7; 144.7; 136.4; 130.6; 129.7; 128.4; 127.4; 126.0

ESI-MS (DUIS, + ion): 519 (2M + K+, 100%); 279 (M + K+, 96%)
ESI-MS (DUIS, - ion): 441 (2M- + K+, 89%); 201 (M-, 100%)
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Preparation of 4-nitrocinnamylidenepyruvate (24).
Potassium (3E,5E)-6-(4-nitrophenyl)-2-oxohexa-3,5-dienoate (Scheme 4, 24) synthesis
began with 1.456 g (8.222 mmol) trans-4-nitrocinnamaldehyde and 1.351 g (12.28 mmol) sodium
pyruvate, suspended in 25 mL. NaOH, 0.1133 g (2.832 mmol), was dissolved in 25 mL CH3OH,
added to the reaction mixture, and quantitatively transferred with 10 mL CH 3OH. The mixture
was placed under an atmosphere of N2 and heated at reflux for 3.5 h before the starting aldehyde
was no longer visible by TLC (25% CH3CN/CH2Cl2 Rf: 0.87). The mixture was allowed to cool to
room temperature, concentrated with rotary evaporation, and placed under vacuum overnight
to afford 2.133 g of a brown solid. The crude product, 2.132 g, was added to 120mL 18Ω H2O and
100mL TEA. CO2 was bubbled into the mixture until it became homogeneous, extracted with six
100 mL portions CH2Cl2. The organic extracts were combined, dried over MgSO4, filtered,
concentrated with rotary evaporation, and placed under vacuum to yield 2.372 g of a dark brown
solid. The dark brown solid was 1.539 g and was mixed with 140 mL EtOAc. That was heated to
boiling before the supernatant was decanted, cooled to room temperature. Potassium 2ethylhexanoate, 1.357 g, was dissolved in 50mL EtOAc was added to the supernatant, producing
a precipitate. The solid was collected by centrifugation, washed with two 40 mL portions EtOAc,
and dried under vacuum to produce 0.2123 g of the crude product which was recrystallized from
12 mL CH3OH and 15 mL EtOAc. After concentrating to 10 mL total volume the mixture brought
to room temperature and placed on ice for several minutes before collecting the solid by
centrifugation and drying under vacuum to yield 0.1257 g (5% yield) trans-4nitrocinnamaldehyde (98% pure, 2% pyruvate mp = 198˚C (darkens from brown to dark brown).
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1H

NMR (300MHz, D2O): δ8.21 (d, J=8.4Hz, 2H); 7.72 (d, J=8.7Hz, 2H); 7.46 (qAB, J=15.3Hz, 8.4Hz,

1H); 7.20 (m, 2H); 6.46 (d, J=15.6Hz, 2H)
13C

NMR (300MHz, D2O): δ198.9; 173.6; 150.9; 149.0; 144.1; 142.4; 132.3; 129.9; 129.0; 125.8

MS (DUIS, + ion): 324 (M + K+, 89%), 150 (C8H7NO2 + H+, 100%)
MS (DUIS, - ion): 531 (2M-+K+, 65%); 493 (2M-+H+, 69%); 246 (M-, 38%); 202 (M- - CO2, 100%);
Steady State Enzyme Kinetics.
All 0.5 mL kinetic assays were conducted in triplicate at 25 °C in 50 mM Bis-Tris (pH 7.0)
for Table 2. The kinetic assays observed in Table 3 and 4 were also at 25 °C, but in 100 mM BisTris pH 6.5 on a TgK DX2 stopped-ﬂow instrument. The initial velocity of Sbi_00515-catalyzed
hydrolysis of 1 was measured directly by monitoring the decrease in absorbance at 330 nm.
Likewise, initial velocities of Sbi_00515-catalyzed condensation of pyruvate with various
aldehyde substrates was also monitored directly. Extinction coeﬃcients and optimal wavelengths
for monitoring the reactions are listed in Table 2. The extinction coeﬃcients were determined
empirically by comparing appropriate peaks in the proton NMR spectra of the various enone
products produced in the condensation reactions with the peak for the α-proton of tryptophan
(added to the NMR samples as a standard) to estimate the concentration of the product. The
tryptophan stock concentration was calculated from the absorbance at 280 nm and the known
extinction coeﬃcient (5540 M−1 cm−1) 7. The kcat and KM values were determined from the initial
velocity data using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of the
aldehyde or benzylidenepyruvate substrate, v0 is the initial velocity, Vm is the maximal velocity,
and KM is the Michaelis constant.
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High-Performance Liquid Chromatography (HPLC) Analysis of Sbi00_515 Reaction Mixtures.
Reaction mixtures (500 μL) containing 12.3 mM 1 in 50 mM sodium phosphate (pH 7.4)
and 5.7 μM enzyme, as well as authentic standards of 1 and 2, were separated using a 50 mm ×
2.0 mm, 2.5 μm Synergy Polar RP column (Phenomenex) on an Agilent 1220 HPLC system. The
gradient ran from 5 to 50% acetonitrile in a 0.1% TFA/water mixture over 8 min at a ﬂow rate of
0.5 mL/min. Analytes were detected by absorbance at 260 nm. All samples were incubated for
50 min at RT before being passed through 10k molecular weight cutoﬀ centrifugal ﬁlter devices
to remove the enzyme.
1H

NMR Analysis of Sbi_00515 Reaction Mixtures.
Reaction mixtures (500 μL) contained 2.8 μM Sbi_00515 and 12.5mM 1 or 50mM 2 with

50 mM pyruvate in 50 mM sodium phosphate buﬀer (pH 7.4). The reaction mixtures were
incubated at RT for 80 min (1) or 35 min (2 with pyruvate), after which the samples were
evaporated to dryness in a CentriFan centrifugal evaporator. The residues were resuspended in
500 μL of D2O. NMR spectra were recorded at RT on a Bruker DRX500 500 MHz spectrometer
equipped with a BBI probe. All data sets consisted of 128 scans. Standard samples of 1 (12.5 mM)
and the mixture of 2 with pyruvate (50 mM each) were treated in the same way as the enzymatic
reaction mixtures.
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3.3 Results and Discussion
Sbi_00515 was ﬁrst assayed for acetoacetate decarboxylase activity as described by
Highbarger et al 8. Because Sbi_00515 shares the same active site residue changes relative to
CaADC that were observed in ShMppR, it was not surprising that it did not react with
acetoacetate. As ShMppR was shown to react with pyruvate, a number of α-keto acids, including
glyoxylate, pyruvate, oxaloacetate, and α-ketoglutarate, were tested as substrates for Sbi_00515.
While
pyruvate,

glyoxylate,
and

α-

ketoglutarate

were

observed

form

to

Scheme 1. Sbi_00515 catalyzed reaction of benzylidenepyruvate (1).

Schiﬀ

base

complexes in X-ray diﬀraction experiments, and the enzyme binds pyruvate with a KD of 5.7 ± 0.6
mM as measured by ﬂuorescence titration, none of these were decarboxylated by the enzyme as
judged from HPLC analysis of reaction mixtures.
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Figure 16. (A) Sbi00515-catalyzed cleavage of 1 observed by UV−vis spectroscopy. The spectra are separated by 4.5 min and
thus cover a 90 min period. The 500 μL reaction mixture contained 100 mM 1 and 12.8 μM Sbi_00515 in 10 mM MES (pH
6.0). The reaction was initiated by the addition of enzyme. (B) HPLC analysis of reaction mixtures and authentic benzaldehyde
(2) suggests that Sbi_00515 catalyzes the hydrolysis of 1 to give 2 and pyruvate (3). Starting material (1, blue trace) and
benzaldehyde, the putative product (2, red trace), are very well resolved, eluting at 6.3 and 3.9 min, respectively. A sample
containing 12.3 mM 1 and 5.7 μM Sbi_00515 (green trace) clearly shows a loss of starting material with corresponding
accumulation of a product that also elutes at 3.9 min under these conditions. (C) Proton NMR spectra of reaction mixtures
and standards confirm that the products of the reaction between Sbi00515 and 1 are 2 and pyruvate. The authentic starting
material (1, red trace) gives a spectrum that is distinct from that of benzaldehyde (cyan trace). The doublet at 6.8 ppm is
characteristic of the unsaturated bond. The methyl protons of pyruvate give a singlet at 2.25 ppm (cyan trace). After
incubation with the enzyme, pyruvate is clearly present (green trace). Given 50 mM pyruvate, the reaction can be run in
reverse (purple trace), where the doublet at 6.8 ppm confirms the production of 1. Together, these data confirm that
Sbi_00515 has in vitro aldolase-dehydratase activity.
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The similarity of the Sbi_00515 structure to that of ShMppR suggested that it should be
able to react with α-keto acids. Sbi_00515 was tested for activity with benzylidenepyruvate [1
(Scheme 1)], as any reaction resulting in modiﬁcation of the double bond (e.g., hydration) would
disrupt the chromophore and be accompanied by a change in the UV−vis absorbance spectrum.
UV−vis spectroscopy (Figure 16 A)
showed that incubation of 1 with
Sbi_00515 resulted in the time
dependent loss of absorbance at 300
nm and a concomitant increase in
absorbance at 254nm. The structure
of 1 and the rise of a species
absorbing at 254 nm suggested that
1 was being hydrolyzed to give
benzaldehyde (2) and pyruvate [3
(Scheme 1)]. Comparison of the
Scheme 2. Aldehydes used in substrate screen I (Table 2).

reaction

mixtures

with

pure

pyruvate and benzaldehyde by reverse phase HPLC analysis confirmed that these were the
products of the reaction (Figure 16 B). This was confirmed further by 1H NMR spectroscopy
(Figure 16 C). These data clearly indicate that Sbi_00515 was able to hydrate the double bond of
1 and catalyze the retro-aldol cleavage to give benzaldehyde and pyruvate. This same reaction
has been observed in the trans-o-hydroxybenzylidenepyruvate hydratase-aldolase from
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Pseudomonas fluorescens, though this enzyme appears, from secondary structure prediction, to
have the TIM barrel fold typical of Schiﬀ base-forming aldolases 9, 10.
Since these end-point assays were conducted over relatively long time periods (30−120
min), it was possible that the reaction observed was cryptic and did not represent the
physiological activity of the enzyme. To address this question, both the hydrolysis and
condensation reactions were characterized by steady state enzyme kinetics. Though the
reactions are clearly catalytic, the modest values of the pseudo-second-order rate constants of
54, 62, and 100 M−1 s−1 when 1, 2, and 3 are varied, respectively (Table 2), suggested either that
these compounds are nonideal substrates that participate in a facsimile of the native reaction for
this enzyme or that they induce nonphysiological chemistry that is only evidence of reaction
promiscuity. To clarify this point, a number of additional aldehyde substrates (Scheme 2) were
screened for activity with saturating pyruvate (Table 2). Interestingly, 4-hydroxybenzaldehyde (4)
has a pseudo-second-order rate constant comparable to that of 2; however, the KM value is
approximately 200-fold less than that of 2, and kcat is more than 300-fold slower. This may
indicate that Sbi_00515 binds 4 more tightly, but in an orientation that is less favorable for
catalysis. Moving from the aryl aldehyde 2 to aliphatic aldehydes 5−11 results in a marked
improvement in KM with small decreases in kcat, such that the catalytic efficiency improves by as
much as 2 orders of magnitude. There is a clear trend of decreasing KM with increasing chain
length going from 6.6 ± 0.4 mM for 5 to 35.0 ± 2.0 μM for 11. There is no clear relationship
between substrate size and the kcat values.
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Table 2. Steady State Kinetic Parameters Measured for the Reaction of 2.0 μM Sbi_00515 with the Enone Substrate 1 in the
Absence of Pyruvate or in the Presence of Saturating Concentrations of Pyruvate (50mM) and Various Aldehyde Substrates
(see Schemes 1 and 2), Subsaturating Concentrations of 2 (50mM) and Pyruvate (3), or Saturating Concentrations of 12
(10mM) and Pyruvatea
product
substrate

kcat (sec-1)

kcat/KM (M-1 sec-1)

KM (mM)

ε (M-1 cm-1)

λmon (nm)

benzylidenepyruvate (1)

1.2 ± 0.2

22.3 ± 7.0

5.4 ± 1.9 x 101

300

24159

benzaldehyde (2)

3.2 ± 0.2

51.5 ± 6.1

6.2 ± 0.8 x 101

300

11426

4-hydroxybenzaldehyde (4)

0.01 ± 0.001

0.4 ± 0.1

2.5 ± 4.0 x101

360

1217

trans-2-pentenal (5)

1.2 ± 0.1

6.6 ± 0.4

1.8 ± 0.1 x 102

290

26021

trans-2-hexenal (6)

12.9 ± 0.6

1.8 ± 0.1

7.2 ± 0.5 x 103

290

8576

hexanal (7)

no reaction

‒

‒

‒

‒

2,4-heptadienal (8)

0.90 ± 0.04

0.3 ± 0.02

3.0 ± 0.2 x 103

360

2432

trans-2-octenal (9)

7.8 ± 0.3

0.4 ± 0.04

2.0 ± 0.2 x 104

330

447

2,4-octadienal (10)

7.2 ± 0.2

0.7 ± 0.1

1.0 ± 0.1 x 104

380

1613

3,7-dimethyl-2,6-octadienal

0.28 ± 0.01

0.04 ± 0.002

7.0 ± 0.4 x 103

330

3393

trans-3-(2-furyl)acrolein (12)

22.9 ± 0.8

1.2 ± 0.08

1.9 ± 0.1 x 104

390

10062

pyruvate (3)b

1.8 ± 0.1

17.2 ± 2.8

1.0 ± 0.2 x102

300

‒

pyruvate (3)c

22.5 ± 1.2

11.8 ± 1.6

1.9 ± 0.3 x 103

390

‒

(citral, 11)

aAs

described in the text, the poor binding and limited solubility of 2 made it impossible to fully saturate the enzyme. The
kinetic parameters apply to the substrate in column 1. The extinction coefficients given are for benzylidenepyruvate itself (row
1) and the condensation products of pyruvate with the aldehyde substrates tested (remaining rows). bBecause of the high KM
value for 2, reaction mixtures were not saturated with respect to this substrate. cReaction kinetics of pyruvate with 12 were
nearly saturated (the concentration of 12 was about 10-fold greater than the measured KM value).

The complete lack of activity with 7, as judged by HPLC analysis shows that the unsaturated bond
adjacent to the aldehyde group is required for the observed catalysis. There also does not appear
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to be a relationship between the kinetic values for 9 and 10, suggesting that the chemistry is
taking place between the aldehyde
and pyruvate. The greater the
degrees of freedom of 9 due to its
lack of a second double bond is
negligible. The tunnel from the
surface to the active site may force
9 to adopt a conformation that
mimics the shape of 10. The βmethyl of 11 is likely responsible
for the slower kcat compared to 10
and

12,

as

the

protruding

functional group sticks out into the
tunnel of the active site.
Scheme 3. Aldehydes used in substrate screen II (Table 3).

The aromatic aldehyde 3(2-furyl)acrolein (12) was chosen because it combines a short, unsaturated alkyl chain with an
aromatic group. This substrate was significantly more efficient than any of the other substrates
tested with a kcat value of 22.9 ± 0.8 s−1 and a KM value of 1.2 ± 0.1 mM, for a pseudo-secondorder rate constant of 1.9 × 104 M−1 s−1. It is interesting to note that the diene substrate 8 reacts
20-fold more slowly than 12 despite the high degree of similarity of their structures. The ability
of the furan ring to accept a hydrogen bond and/or stack with an aromatic side chain in the active
site may result in 12 binding in a more favorable orientation for catalysis.
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Table 3. Steady State Kinetic Parameters Measured for the Reaction of 0.1 μM Sbi_00515 in the Presence of Saturating
Concentrations of Pyruvate (50mM) and Various Aldehyde Substrates (see Scheme 3), or Saturating Concentrations of 14
(1mM) and Pyruvate.
product
substrate

kcat (sec-1)

KM (µM)

kcat/KM (M-1 sec-1)

ε (M-1 cm-1)

2-benzofurancarboxaldehyde (13)a

7.3 ± 0.2

699.4 ± 45.7

1.0 ± 0.1 x 104

10749

trans-cinnamaldehyde (14)

28.3 ± 0.4

52.9 ± 1.6

5.4 ± 0.2 x 105

17050

2-methoxycinnamaldehyde (15)

15.7 ± 0.4

100.2 ± 4.0

1.6 ± 0.1 x 105

11908

4-methoxycinnamaldehyde (16)

3.3 ± 0.1

13.1 ± 0.9

2.5 ± 0.2 x 105

46035

3-methoxy-4-hydroxycinnamaldehyde (17)

1.7 ± 0.1

117.2 ± 19.6

1.5 ± 0.3 x 104

34851

3-(3-pyridyl)acrolein (18)

398.2 ± 2.3

191.6 ± 2.1

2.08 ± 0.03 x 106

5117

α-methyl-trans-cinnamaldehyde (19)

2.0 ± 0.1

426.9 ± 58.8

4.7 ± 0.7 x 103

12624

trans-2-nitrocinnamaldehyde (20)

24.7 ± 0.6

30.6 ± 3.0

8.1 ± 0.8 x 105

11963

trans-4-nitrocinnamaldehyde (21)

10.2 ± 0.1

3.1 ± 0.1

3.3 ± 0.2 x 106

49616

pyruvate (3)b

22.3 ± 0.4

2914 ± 181

7.7 ± 0.5 x 103

‒

The λmon (nm) for each substrate was 360, except for a, which was 380 nm. bReaction kinetics of pyruvate with 14 were nearly
saturated (the concentration of 14 was about 20-fold greater than the measured KM value).

Finally, the relatively robust activity with 12 does suggest that the aldol condensation and
dehydration activity of Sbi_00515 is real, and not a spurious reaction resulting from the presence
of a reactive enamine in the active site. It should also be noted that the aldol condensation
activity was observed only with pyruvate. Other α-keto acids that were tested, such as glyoxylate,
2-oxobutyrate, oxaloacetate, and α-ketoglutarate, did not react with any of the aldehyde
substrates used in this study. Like the Type I lysine-dependent aldolases, Sbi_00515 is specific for
its donor substrate, pyruvate, and promiscuous with respect to the acceptor, aldehyde substrate.
An estimated 1 in 10 enzymes adopt the TIM barrel fold 11, or (β/α)8, fold including Type
I and II aldolases. Type I aldolases have an essential active site lysine residue that is involved in
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Schiff

base

formation

with a donor substrate,
pyruvate

12.

Type

II

aldolases function with a
metal ion, typically Zn+, as
a cofactor 13. The general
mechanisms for Type I
and II aldolases are shown
in Scheme 4. The Type I
sialic acid aldolase, NScheme 4. The general mechanisms for Type I and II aldolases.

acetylneuraminate lyase

(NAL), catalyzes the reversible aldol cleavage of N-acetylneuraminic acid (Neu5Ac), the most
abundant of sialic acids, to form pyruvate and N-acetyl-D-mannosamine (ManNAc) 12. Sialic acid
aldolase, as mentioned in chapter 2, Figure 13, uses an active site lysine to form a Schiff base to
C2 of an α-keto acid moiety of the substrate 12. The WT structure of Pasteurella multocida NAL
shows the that the active site tyrosine (Tyr136) lies almost parallel to the Schiff base
intermediate, and is involved in the hydrogen bonding network with the substrate 12. Tyr136 is
proposed to take a hydrogen from the active site lysine, and transfer it to the carbonyl (C2) of
pyruvate with the release of a water molecule. The structure, PDB ID 4IMD, shows a conserved
water molecule 2.7 angstroms from Tyr 136 and 2.8 Å from the Schiff base intermediate.
Although the study by Huynh et al. calls the pyruvate-bound structure the Schiff base
intermediate, there is no way to tell at 2.10 angstrom resolution whether pyruvate is bound as
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the imine or enamine

12.

Another study uses crystal structures, as well as quantum

mechanics/molecular mechanics (QM/MM) and site-directed mutagenesis to test the catalytic
importance of the active site tyrosine 14. This time, an E. coli NAL was used, and demonstrated
Y137F had about 570-fold lower kcat/KM, with approximately the same KM values, and no activity
with Y137A. QM/MM sampled molecular dynamics, and in all cases observed a spontaneous
proton transfer from the active site Tyr137 to the ManNAc aldehyde oxygen

14.

QM/MM also

proposed the use of water in the breakdown of the Schiff base and the substrate/product, and
reprotonate the Tyr137 phenolate 14.
Adding a bulkier aromatic group than the furan ring of 12 continued to decrease KM values
by an order of magnitude (compare values in Table 2 to 3). Comparing 12 and 13, the kcat values
are approximately equal, while the KM values differ significantly. The combination of an
unsaturated aliphatic aldehyde with a phenyl group is a better match to the shape of the funnellike active site. In contrast, active sites of the true ADCs are long, narrow tunnels, reflecting their
smaller substrate 2. The lower KM values in Table 3 suggest that the increased bulk allows for
more extensive van der Waals contacts between the aldehyde and the active site funnel. In
addition, the aromatic group and trans double bond of the aliphatic portion of these aldehydes
matches the shape of the active site and creates the potential for π-π interactions with aromatic
side chains lining the funnel. While none of the cis counterparts of this series of aldehydes were
tested for activity, one might speculate that they may not bind as well, since a cis compound
would require a spontaneous cis-trans isomerization before it could be accommodated in the
active site.
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Trans-cinnamaldehyde (14) was a favorable scaffold for investigating the effects of
substituents on the phenyl ring, as cinnamaldehyde analogs are commercially available. The KD
for trans-cinnamaldehyde was 45.8 ± 4.1 µM. It would have been more advantageous to vary the
same substituent around the phenyl ring to control for effects due to the identity of the
functional group, however the compounds in Scheme 3 were those available for purchase. The
ortho or para positions were more efficient substrates than those in the meta position. The para
position for 16 and 21 had a smaller kcat, but a tighter KM than 15 and 20, leading to a higher
pseudo-second-order rate constant. When 16 and 21 are modeled into the active site using the
pyruvate-bound structure as an anchor for the pyruvate moiety, both of these compounds more
completely filled the active site than 14, and 21 had a tighter KD at 14.36 ± 1.32 µM. The more
extensive van der Waals contacts with these para-substituted cinnamaldehydes likely accounts
for the lower KM values. The kcat values for 16 and 21 may be smaller than 15 and 20, which
contain a methoxy and nitro group, respectively, in the ortho position, due to their positions
further into the active site than the para positions. Therefore, the contacts are in the tunnel lining
the active site, not with bulk solvent like the para versions, which could effectively shield them
from any additional van der Waals interactions (15) or hydrogen bonding (20). Substituents in
the meta position appear to interfere with binding, as evidenced by the the 16-fold slower kcat of
17. The para substituent of 16 fully fills the active site in modeling, the meta position of 17 juts
out into the hydrophobic residues lining the active site. Surprisingly, 3-(3-pyridyl)acrolein (18) has
a much faster turnover number than the rest of the substrates in Table 3, however the KM is
almost 200 µM. This could be due to 18 having a lone pair of electrons on the aromatic ring,
which could influence how it binds in the active site. The α-methyl group of 19 clashes with the
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active site, resulting in lower kcat and specificity
constant. Based on the values from Table 3.2 for
trans-4-nitrocinnamaldehyde, 21 is a highly efficient
substrate, though not necessarily the physiological
one. 14 was used with pyruvate for steady state
kinetics in Table 3.2 due to better solubility. The
steady state values for pyruvate from Table 3
increased slightly for the pseudo-second-order rate
Scheme 5. Compounds used for retro-aldol
cleavage (Table 4).

constant, decreased for KM, yet maintained the same
kcat compared to the values in Table 2. Perhaps there

is a limit to the turnover number, and the subtle changes in apparent binding affinity and
specificity constant reflect the preference for aromatic, unsaturated aliphatic groups for
aldehyde acceptors.
After substrates 2-21 were tested for the synthetic direction, specific substrates (12, 14,
21) were chosen to combine with pyruvate to observe the reversibility of Sbi_00515 (22, 23, 24),
as seen in Scheme 5. The compounds for catabolic catalysis are in Scheme 5, and steady state
kinetics observed in Table 4.
Table 4. Steady State Kinetic Parameters Measured for the Reaction of 0.1 μM Sbi_00515 in the Presence of 22, 23, or 24.
product
substrate

kcat (sec-1)

KM (µM)

kcat/KM (M-1 sec-1)

ε (M-1 cm-1)

3-(2-furyl)acrolenepyruvate (22)a

0.21 ± 0.02

52.9 ± 8.3

4.0 ± 0.7 x 103

10,062

cinnamylidenepyruvate (23)

1.57 ± 0.04

24.9 ± 1.7

6.3 ± 0.5 x 104

17,050

4-nitrocinnamylidenepyruvate (24)

0.68 ± 0.04

8.5 ± 0.9

8.0 ± 1.0 x 104

49,616

The λmon (nm) for each substrate was 360, except for a, which was 390 nm.
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Scheme 6. Non-reactive compounds for Sbi_00515 with saturating pyruvate (3).

The benzyl groups of 23 and 24 are an order of magnitude greater in their specificity constants
than that of the furyl ring of 22. The better KM values of 23 and 24 compared to 22 suggest the
former fills out the active site more fully, by forming more π-π stacking and van der Waal
interactions. 24 has a slower turnover rate than 23, which may be due to better KM values.
Nevertheless, 22-24 are all 1-2 orders of magnitude lower in pseudo-second-order rate constants
when contrasted against their synthetic, anabolic counterpart reaction. If there is excess
pyruvate in the bacterium 15, that would drive catalysis in the synthetic direction.

64

Numerous other small compounds were tested in saturating, 50mM pyruvate that
demonstrated no activity with Sbi_00515 (Scheme 6). First, other benzaldehyde-like compounds
were tried. 25-27 may have been influenced by the electronegative atoms within the ring to
explain why no reaction with pyruvate and Sbi_00515 occurred. There also could have been
unfavorable or unreactive binding in the active site. Benzaldehyde derivatives 28 and 29 did not
react. This is likely due to benzaldehyde being a modest substrate to begin with, and the
additional electronegative nitrogens could have had an inductive effect, bound to a functional
group in the active site to prevent catalysis, or not being able to bind Sbi_00515 without greater
than mM quantities. Compound 30 was tested to compare to the 2-benzofurancarboxaldehyde
compound (13), and the fact that a nitrogen in the ring system could behave, as 3-(3pyridyl)acrolein does. 30-34 were tested as a confirmation that only an unsaturated aliphatic
aldehyde would reaction. Hydrocinnamaldehyde, 30, has too many degrees of freedom to
undergo catalysis. There is no unsaturation in the aliphatic portion to keep 30 in a conformation
near the aldehyde to direct it towards the pyruvate in the active site for catalysis. 32 ‒ 34
confirmed that an aldehyde was the only functional group able to react with pyruvate in
Sbi_00515.

3.4 Conclusions
The steady state kinetic data presented here show that Sbi_00515, a protein of unknown
function from S. bingchenggensis, has in vitro pyruvate aldolase-dehydratase activity and is not
an acetoacetate decarboxylase as it is currently annotated. Based on this activity, it is proposed
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that Sbi_00515 be renamed to Streptomyces bingchenggensis Aldolase-Dehydratase, SbAD. This
is the first Schiff base-forming aldolase known to use a fold other than the TIM barrel. Given the
proximity of the gene encoding SbAD to an uncharacterized polyketide biosynthetic cluster and
the strong preference for an unsaturated aldehyde substrate, it is tempting to speculate that
SbAD might synthesize an unusual starter or extender unit for the polyketide. However, more
detailed genetic and biological studies must be conducted before anything substantive can be
concluded in this regard. Other lysine dependent (TIM barrel) aldolases have been used in protein
engineering and as templates to generate enzymes that catalyze reactions not found in nature,
as mentioned in the introduction of chapter II 16, 17. The discovery of SbAD and the versatility of
the ADC fold may influence how proteins are engineered, but more mechanistic studies need to
be done. Numerous work has been done on TIM barrels, as mentioned previously, for
engineering, however the ADC fold has not been considered in these endeavors. The funnel of
the active site, lined with hydrophobic residues, could be engineered with bulkier groups to
narrow the site, or changed to polar groups and accept for hydrogen bonding substrates. ADC
could function as a group to hold potential active sites of designed transition states as de novo
work, however it remains to be tested.
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CHAPTER IV: ELUCIDATING THE MECHANISM OF SbAD
4.1 Introduction
Steady state kinetics can indirectly probe the order of addition of substrates and release
of reactants and products however transitory intermediate information after the substrate(s)
bind is not observable by this technique 2. The pre-steady state, with half-times of less than one
second, is the initial period during which intermediates form, and lasts until the steady state is
reached 3-5. The most widely used method of studying fast reactions is stopped flow 3. Figure 17
illustrates the basic set-up of the instrument. Rapid spectral acquisition via stopped flow can be
done by diode-array or a photomultiplier tube (PMT) 2. Diode-array mode can detect and
integrate all of the light for the exposure time to record a snapshot of the spectrum of the
reaction solution by
using a high-intensity
xenon lamp, whereas
PMT mode observes a
reaction at a specific
2.

wavelength

The

diode-array mode has
a

loss

in

time

resolution, but covers
a
Figure 17. Simplified schematic of a stopped flow apparatus, adapted from TGK Scientific 1.
The drive syringes are labeled A and B.
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range

of

wavelengths, whereas

a specified wavelength in PMT mode has excellent time resolution. Arrays may not always be
able to show parts of the spectrum of interest, but may show intermediates one might not see
at a single wavelength (e.g. if the reaction were being monitored at an isosbestic point). The
reaction is started by pushing the plungers of the two drive syringes simultaneously to cause the
reactants to mix. The mixture is then forced through the observation cell, and into the stopping
syringe 3. The mechanical stop activates the detecting and recording system, as well as prevents
further mixing. The time between the start of mixing and the start of recording, for instance,
absorbance, is known as the dead time, during which the reaction cannot be observed. For most
instruments it is usually on the order of a 1‒2 milliseconds

3, 7.

Steady state kinetics forms the

basis of transient state kinetics 8.
Most experiments are done under pseudo-first order conditions in order to simplify a
reaction. The benefit of this in transient kinetics is the direct measurement of reactions at the
enzyme active site in order to determine the thermodynamic (equilibrium) and kinetic
foundations for enzymatic specificity and efficiency

9, 10.

Even under pseudo-first-order

conditions, the data can deviate from a simple, single exponential. One such deviation is a burst
phase at the earliest time points, which is indicative of a build-up of intermediate on the way to
the establishment of the steady state 2. Burst kinetics may indicate a covalent intermediate in
the reaction, or that product release is the rate-limiting step in the mechanism. The magnitude
of the intercept of the burst is typically proportional to the enzyme concentration 3. There may
also be deviations from simple, monophasic data that can arise due to contributions from more
than one intermediate during a time course 5. One method to resolve such ambiguities is singleturnover kinetics. The enzyme in excess over substrate concentration allows for direct
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observation of the conversion of substrates to intermediates and products in a single pass of the
reactions through the enzymatic pathway 9. Reactant can be titrated, or chemical agent is added
to stop the reaction after one turnover

11.

Although this method can directly determine rate

constants, an excess of enzyme is not a trivial matter, as depending on the binding constants of
the substrates used, this might require a large or even unrealistic concentration of protein.
The goal of data fitting in transient kinetics is to establish the reaction pathway by
investigating the concentration dependence on the rate of the reaction 9. Unlike steady state
kinetics, which fit initial rate data via simple linear regression, pre-steady state kinetic data are
fit to integrated equations from simple (pseudo-first order) rate equations. This involves fitting
the data to an equation fitting the time dependence of the reaction. Solutions of differential
equations describing the pseudo-first order reaction will be a sum of exponential terms, with a
single exponential as an example:
𝑌 = 𝐴𝑒 −𝑘𝑡 + 𝐶
where A is the amplitude, k is the rate of the reaction, t is the time, and C is the end point 9.
Nonlinear regression methods are used in an iterative approach for best fit, including the
minimization of the sum of square error between the fitted and raw data 9. Throughout the data
fitting process, overfitting the data is a cause for concern. Programs that solely use singular value
decomposition may rely too heavily on Chi2 values, instead of global fitting, as found by the work
of K. Johnson 11-14. Computer simulations of a proposed kinetic mechanism is another important
method to determine the validity of the rate constants obtained experimentally from transient
(as well as steady state) kinetics. A model of the proposed mechanism is fit to rate constants (and
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other values in global fitting), and allowed to digitally proceed. The comparison of the modelled
mechanism and experimental values indicate the accuracy of the predicted mechanism, whereby
overfitting is again cause for misleading rate constants 11.

Figure 18. Simplified examples of inhibition, where A is substrate, E is enzyme, I is inhibitor, and P is product. (A) Competitive
inhibition: Apparent increase in KM, no change in V. (B) Mixed inhibition: apparent V and V/KM are decreased. (C)
Uncompetitive inhibition: Apparent V is decreased, V/KM unchanged. Not pictured is rare, pure non-competitive inhibition:
apparent V decreased, KM unchanged 3.

Steady state and transient kinetics are complementary techniques. For instance, a
transient single turnover kinetic experiment may give clues about the order of addition of a two
substrate reaction, but not conclusive results. In that case, initial velocity studies with inhibitors
is another approach to distinguish between possible mechanisms 2. Different approaches can be
used, depending whether the enzyme exhibits substrate or product inhibition, allosteric
regulation, tight-binding/slow-binding inhibition, or whether an inhibitor binds irreversibly or
reversibly in the active site. In reversible inhibition, different types of inhibition are possible,
based on the classic definitions: competitive, mixed, uncompetitive, or pure noncompetitive
inhibition 2, 3, 15. Illustrations of the terminology are in Figure 18; this is necessary as even within
the field there is not good agreement as to what these terms actually mean. Plots of the initial
velocity experiments shed light on the type of inhibition used based on fitting the experimental
data 16, 17.
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One of the most powerful physical organic chemistry tools in mechanistic enzymology is
the kinetic isotope effect (KIE), as it can describe what bonds have been broken, formed, or
rehybridized during a rate-limiting step

3, 18.

A KIE can be defined as “a change in the rate or

equilibrium constant of a reaction upon substitution of a heavy atom for a light one at or adjacent
to the position of bond cleavage in a molecule undergoing reaction.” 2 Isotopes are isosteric and
isoelectronic as they reflect changes in vibrational frequencies of reactants going to products,
and therefore do not alter the mechanism of a reaction, just the observed rate constant of a
sensitive step 2. A primary isotope effect occurs when a bond is made or broken to the isotopic
(heavy) atom during a reaction, and a secondary isotope effect occurs when the bonding to the
isotopic atom changes, but no bonds were broken or made 19, 20. A secondary KIE is largely due
to hybridization changes, whereas a primary KIE mainly arises from the difference in mass on
vibrational energy levels. If the heavy atom is attached to the bond undergoing cleavage, it is
known as α, whereas if it is in a position attached to an atom adjacent to the one undergoing
cleavage, it is known as β. When the bonds being made, broken, or rehybridized involve
hydrogen/deuterium, the effect is relatively large and can be measured. KIEs with other atoms
have been studied, but the effects are small and difficult to quantify 18. Isotope effects are given
as the ratio of rate constants with light and heavy atom substitutions, for instance

𝑘𝐻
⁄𝑘 . The
𝐷

ratio is said to be “normal” if it is above unity, or one, and “inverse” if it is less than one. There
are three ways to measure isotope effects: direct comparison of initial rates, equilibrium
perturbation, and the most sensitive method, internal competition, as it follows the changes in
the isotopic ratio as the reaction proceeds 2, 21. Like all kinetic measurements, careful attention
needs to be paid to the proposed step at hand, as overfitting data can affect analysis, or intrinsic
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isotope effects on Vmax values may be masked by slower chemical steps that are not isotopesensitive 20, 22-24.
The techniques explored above are done in a buffer of specific pH, since enzymes are
profoundly affected both structurally and functionally. Most enzymes possess a number of
ionizable groups distributed across their surface and in the active site 3. A pH-rate profile can
illustrate the required state of protonation of groups required for binding and/or catalysis, but
may also reflect the stability of the enzyme over the pH range 2. Thus, pH-rate data are
notoriously difficult to interpret. The estimated pKa value from a plot of log (V) versus pH, for
example can be tested by mutating the residue in question to an amino acid that cannot ionize,
and repeat the pH-rate profile for verification. Even in this case, though, the mutation might alter
the environment of the active site and thus shift the pKa of a different residue; the observed
effect of the mutation may not be due to the pKa of the mutated residue. A single or double

Figure 19. The image is from Gill et al.6 for a DSC experiment. ΔT is the amount of heat required to raise the temperature by
the same amount. qs and qr are the heat flows for the sample and reference cell, where qs requires more heat than qr due to
the contribution of protein in the cell, Δq. The scan for qr is subtracted from qs to the resultant Δq. ΔHd is the change in
enthalpy, ΔCp,d is the change in heat capacity, Tm is the transition and melting point, and d is denatured.

74

mutant in the active site of an enzyme can hint towards its involvement in catalysis and/or
binding in a reaction. Sometimes, a mutant can not only drastically change the activity of an
enzyme, it may alter substrate specificity, improve trace activities, or lead to a new reaction
mechanism

25.

Steady state and transient kinetics with active site (or other important site)

mutants can further illustrate key residues involved in the mechanism. X-ray crystallography is
another important tool for the characterization of active site mutants. A crystal structure of a
mutant form of the protein may show new binding contacts, or trap an intermediate by slowing
down or inhibiting the mechanism.
Mutant forms of a protein may not crystallize in the same conditions as WT, leading to
complications in enzyme stability. One method to quickly assess buffers, additives, and/or ligands
for stabilization is by a thermal shift assay, also known as a differential scanning fluorimetry or a
ThermoFluor™ assay

26.

The goal of this technique is to establish a connection between

temperature, and a specific physical property; in this case, the denaturation and aggregation of
protein with increasing temperature to find conditions that stabilize the protein. This rapid and
inexpensive technique uses a real-time PCR instrument with the fluorescent SYPRO orange dye
(λex 470 nm/λem 570 nm). SYPRO orange fluoresces upon binding to hydrophobic portions of the
protein, which become more available as the temperature increases and the protein begins to
denature. Monitoring the fluorescence emission as a function of temperature gives a change in
the emission of the dye that indicates the point where 50% of the protein molecules have
denatured: the melting temperature (Tm).
Once buffers, potentially small molecule additives, have been optimized, one can directly
determine the thermodynamics of protein unfolding in more detail by using differential scanning
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calorimetry (DSC). DSC has numerous applications from chemistry to pharmacology and
nanoscience, however one of the focuses in biochemistry, is protein folding 6. When a
macromolecule unfolds, a change in heat capacity is observed. The heat capacity of a folded
protein is higher, because it takes energy to surpass the phase change of folded to unfolded
protein

27.

The increasing disorder of the protein as the temperature rises produces the heat

capacity in the aqueous solution 6. The simplest DSC experiment consists of a reference cell, filled
with only the buffer, and a sample cell, containing the macromolecule in the exact same buffer.
The temperatures of both cells are simultaneously raised. The amount of excess heat absorbed
or released by the molecule in the sample requires the input energy to match the temperature
of the sample to that of the reference 6. Therefore, more energy is required to bring the sample
cell, containing the protein in buffer, to the same temperature as the reference. The power
compensation signal is recorded as the calorimetric output 28. Figure 19 shows a schematic of a
DSC experiment and data analysis. The enthalpy can also be calculated in an indirect, noncalorimetric manner by van’t Hoff analysis 27. This takes an equilibrium constant (K) so that the
standard free energy change, ΔG°, is zero so that:
𝛥𝐺°(𝑇) = −𝑅𝑇 ln 𝐾(𝑇)
where R is the universal gas constant and T is the temperature in Kelvin, and:
𝛥𝐺°(𝑇) = 𝛥𝐻°(𝑇) − 𝑇𝛥𝑆°(𝑇)
where ΔH° is the change in enthalpy and ΔS° is the change in entropy. Combining the equations
produces
ln 𝐾(𝑇) = (

−𝛥𝐻(𝑇)
𝑅
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1

)(𝑇) + (

ΔS°(T)
𝑅

)

and rearrangement gives the van’t Hoff equation
𝑑 ln 𝐾(𝑇)
−𝛥𝐻°(𝑇)
=
𝑅
𝑑 (1⁄𝑇)
If the enthalpy change derived from the van’t Hoff analysis agrees with the value determined by
DSC, then the denaturation process of the protein can be approximated by a two state model,
which states the protein exists in two forms, folded and unfolded 28. If the van’t Hoff enthalpy
value is less than the DSC value, an intermediate during unfolding is likely to have formed 29.
SbAD has undergone ThermoFluor™, DSC, and van’t Hoff analysis to more thoroughly
understand its stability. Based on substrate specificity and functional analysis, cinnamaldehyde
and 4-nitrocinnamaldehyde with saturating pyruvate have been used for study in the synthetic
direction, and cinnamylidenepyruvate and 4-nitrocinnamylidenepyruvate for the catabolic
direction. The proposed mechanism (Figure 20), is based on the observed aldolase-hydratase
activity, and the conserved Schiff base-forming residues from the true ADCs. First, pyruvate binds
in the active site. A carbinolamine is formed on the way to a Schiff base intermediate. The
aldehyde is oriented by Tyr252 before nucleophilic attack to the carbonyl carbon of the aldehyde.
An aldol intermediate is formed, as well as another Schiff base, and then hydrolysis from the
enzyme occurs for product release.
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Figure 20. Hypothetical Mechanism of SbAD.

4.2 Materials and Methods
Materials
Cinnamaldehyde, 4-nitrocinnamaldehyde, 2,3-butanedione, 4-phenyl-3-buten-2-one and
sodium pyruvate were sourced from Sigma-Aldrich.
Cloning, Expression, and Purification of Sbi_00515.
The protein was previously cloned and expressed as described in Chapter II 30.
Preparation of cinnamylidenepyruvate.
The compound was previously synthesized as described in Chapter III.
Preparation of 4-nitrocinnamylidenepyruvate.
The compound was previously synthesized as described in Chapter III.
Transient Kinetics.
Photodiode array data were collected on a TgK DX2 stopped flow instrument under single
turnover conditions. A solution containing saturating, 500 µM, wild-type SbAD was mixed with
an equal volume of 17 µM cinnamaldehyde and 50 mM sodium pyruvate (all concentrations
represent concentrations in the optical cell after mixing). Reactions were monitored at
wavelengths ranging from 317 ‒ 703 nm at 0.8 ‒ 0.9 nm intervals, at 5.0 °C for a total of 1.49
seconds in 50 mM BIS-TRIS pH 7.0. The same conditions were used to study the reverse reaction,
where 17 µM cinnamylidenepyruvate was mixed with 500 µM SbAD WT.
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Transient state kinetics were also done under pseudo-first order conditions to probe the
order of addition. SbAD WT was 491 µM, and saturating pyruvate was 60 mM. The
cinnamaldehyde concentrations varied were 10, 15, 20, 25, 30, 35, and 40 µM final, and buffer
used was 50 mM BIS-Tris pH 7.0. All reactions were at 5.0 °C. Wavelengths were monitored at
360 nm and 430 nm; all reactions were done in triplicate on a 1.0 second time scale. All fitting
was done in OriginPro 2016 Student Version 64Bit.
Kinetic isotope effects with substrates 1H3 and 2H3 pyruvate were done at 5.0 °C in single
turnover conditions. Pyruvate was saturating, 60 mM. Cinnamaldehyde concentrations were 20,
25, 30, 35, and 40 µM final. Experiments were performed on a TgK DX2 stopped flow instrument
with 491 µM SbAD WT in 50 mM BIS-Tris pH 7.0. Wavelengths were monitored at 360 nm and
430 nm; all reactions were done in triplicate on a 1.0 second time scale. All fitting was done in
OriginPro 2016 Student Version 64Bit.
Steady State Burst Kinetics.
Time courses for the reactions with varying concentrations of SbAD WT with saturating
200 mM pyruvate and 500 µM 4-nitro-cinnamaldehyde were performed at 4.0 °C in 50 mM BISTris pH 6.5.
Steady State Inhibition Kinetics.
All assays are the average of triplicate runs. The kinetic assays were done at 25 °C in
triplicate in 100 mM Bis-Tris pH 6.5 on a TgK DX2 stopped-ﬂow instrument. The initial velocity of
Sbi_00515-catalyzed hydrolysis of 1 was measured directly by monitoring the decrease in
absorbance at 360 nm. Likewise, initial velocities of SbAD-catalyzed condensation of pyruvate
80

with cinnamaldehyde and either inhibitor 4 or 7 was also monitored directly. All fitting was done
in GraphPad Prism 5. The equations used to fit steady state kinetic data by non-linear regression
were as follows:
Non-competitive

Y=(Vmax*X/(1+[I]/Ki))/(X+KM)

Uncompetitive

VmaxApp=Vmax/(1+I/AlphaKi)
KMApp=KM/(1+I/AlphaKi)
Y=VmaxApp*X/(KMapp+X)

Mixed

VmaxApp=Vmax/(1+I/(Alpha*Ki))
KMApp=KM*(1+I/Ki)/(1+I/(Alpha*Ki))
Y=VmaxApp*X/(KMApp + X)

Competitive

KMObs=KM(1+[I]/Ki)
Y=Vmax*X/(KMObs+X)

Steady State Mutant Kinetics
Assays were done with 0.1 µM SbAD and mutants in 50 mM Bis-Tris pH 6.5 on a TgK DX2
stopped-ﬂow instrument. The initial velocity of SbAD-catalyzed hydrolysis of 3 and aldolasedehydratase activity of 1 and 2 were measured directly by monitoring in absorbance at 360 nm.
The kcat and KM values were determined from the initial velocity data using the equation v 0 =
Vm[A]/(KM + [A]), where [A] is the concentration of the aldehyde or benzylidenepyruvate
substrate, v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant.
Fluorescence Titration for KD Determination
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All work was done on a Hitachi F-4500 fluorimeter with a fluorescence cuvette in
triplicate. The cuvette was rinsed between each use. 1.0 ‒ 3.0 µM SbAD WT, and mutants were
titrated with substrate at λex 280nm for tryptophan excitation and monitored from 300 ‒ 600 nm
for λem in quenching for tryptophan with substrate. A plot of fractional saturation versus
concentration was fitted against a model equation (Y = X / (X + KD)) to determine KD. SbAD WT
with sodium pyruvate (2) and 4-nitrocinnamaldehyde was done in 100 mM MOPS pH 7.0, and
cinnamaldehyde (1) in 50 mM BIS-Tris pH 6.8. All fitting was done in OriginPro 2016 Student
Version 64Bit and Kaleidagraph.
pH Rate Profile
A tri-buffer system was used containing 100 mM sodium acetate, MES, and TRIS for pH
ranging from 4.0 to 9.0 by 0.5 intervals. All kinetic assays were conducted in triplicate at 25 °C
with 0.1 µM SbAD WT and E84Q on a TgK DX2 stopped-ﬂow instrument. The initial velocity of
SbAD-catalyzed aldolase-dehydratase activity of 1 and 2 were measured directly by monitoring
in absorbance at 360 nm. The kcat and KM values were determined from the initial velocity data
using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of the cinnamaldehyde,
v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant. The plots of
log(Initial Rate) versus [H+] to determine pKa from the equation log(C / (1 + (K2/H) + (H/K1))),
where K1 and K2 are the dissociation constants for the ionization of groups that must be
unprotonated and protonated, respectively, for catalysis, and C is the pH-independent value of
the kinetic parameter of interest 31.
Differential Scanning Calorimetry (DSC)
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DSC was performed on a TA Instruments Nano DSC with 9 ‒ 12 mg/mL enzyme in 100 mM
MOPS pH 7.0. Experiments were done in triplicate after an initial run to obtain an idea of
appropriate temperature range.
Crystallization, Structure Determination, and Model Refinement
SbAD Y252F was previously crystallized as described in Chapter II. Crystals of SbAD Y252F
were soaked in 5 mM 4NCP for two hours before being flash cooled. Molecular replacement from
the SbAD WT (PDB ID 4ZBO) was used to determine phases.
Size Exclusion Chromatography
The solution molecular weight of SbAD WT, D107N, D109A, and D109N was estimated by
gel filtration chromatography using a Sephadex S-200 analytical column on an AKTA FPLC. The
column was calibrated using standard proteins including equine heart cytochrome C (12.4 kDa),
bovine erythrocyte carbonic anhydrase (29 kDa), bovine serum albumin (66 kDa), yeast alcohol
dehydrogenase (150 kDa), and sweet potato –amylase (200 kDa). To define the standard curve,
each protein was dissolved at 10mg/mL in the running buffer and the separation was performed
on 500 μL of the standard mixture at 25 °C. A sample of the SbAD variants (10 mg/mL) was run
immediately afterward using the same column and identical conditions.

4.3 Results and Discussion
No intermediates were detected from the progress curves obtained from steady state
kinetics, which is logical because it is cumulative of all the steps in a mechanism. Single turnover
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transient kinetics were done to detect, if any, intermediates could be detected in the reaction.
Excess SbAD and pyruvate with limiting cinnamaldehyde revealed an increase and concomitant
decrease at 430 nm, previously unseen in other UV-Vis analyses (Figure 21). The appearance of
cinnamylidenepyruvate, the product of the reaction, can be monitored at 340 – 360nm.
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Figure
21.
Cinnamylidenepyruvate
product
formation
occurs at 360 nm. There
is a rise at 430 nm at the
same time as product is
released. The decrease
and steady state of the
longer
wavelength
indicate an intermediate
decrease, and a slow
decrease in the steady
state
as
substrate
(cinnamaldehyde)
is
used.

Figure
22.
Cinnamylidenepyruvate
product
decreases
drastically at 350 nm
while an increase at 430
nm occurs. Once steady
state is reached for 350
nm, it remains linear,
while 430 nm indicates
an intermediate with
the decreased slope.
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The

reversible

reaction

was

also

monitored

with

excess

SbAD

and

limiting

cinnamylidenepyruvate. Again the rise and subsequent fall at 430 nm occurred (Figure 22).

Scheme 7. Proposed intermediate at 430 nm.

The longer wavelength spectra indicate a more conjugated intermediate, which is proposed in
Scheme 7. Inspection at 430 nm revealed a burst of absorbance before attainment of the steady
state rate, as observed in Table 5.
Table 5. Burst kinetics were observed with saturating pyruvate (200mM) and 4-nitrocinnamaldehyde (500 µM).
y = -A exp(-kt) + mx + C
[SbAD WT] (µM)

1.25

2.5

5.0

Amplitude (A)

0.029 ± 0.002

0.063 ± 0.001

0.136 ± 0.003

Burst rate (k, s-1)

262.4 ± 10.7

206.8 ± 2.9

237.1 ± 3.0

Steady state rate (m, A s-1)

0.002 ± 1.0 x 10-4

0.004 ± 1.0 x 10-4

0.009 ± 1.8 x 10-4

The amplitude doubles as the enzyme concentration doubles, confirming the reaction observed
is enzyme catalyzed, and not spurious in solution, likewise with the steady state rate. The burst
rate does not appear to vary with enzyme concentration. This indicates that a rate limiting step,
likely product release, is building up before attainment of the steady state is reached.
Single turnover transient kinetics were repeated: it was anticipated that in order for
cinnamaldehyde to bind and react, pyruvate needed to be bound to the active site lysine first. As
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illustrated in Figure 23, two syringes of the stopped flow apparatus were filled with various orders
of SbAD and substrate. If cinnamaldehyde were to bind first, it appears that pyruvate would not
be able to fit into the narrow active site tunnel. Based on the data from Figure 23, that clearly did
not occur, and the reaction proceeded whether or not cinnamaldehyde was incubated with
enzyme.
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Figure 23. Order of addition reactions were used to determine if there was an observable binding order between pyruvate
and cinnamaldehyde for SbAD WT. The syringe schemes represent the syringes from stopped flow, located above the data.
The left panel in green is from 360 nm, following product formation. The right panel, with blue traces, monitored 430 nm, is
intermediate formation and loss. In both traces, the dashed black line is the fit to the data, interpretation of which is
underneath the figures.
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Based on all of the order of addition experiments in Figure 23, there is no dependence on
concentration for kobs. This implies that if there are any concentration dependent steps, they
occur during the dead time of the stopped flow instrument, or that the substrate-dependent
binding step is invisible. There is an approximately 20 sec-1 advantage to having SbAD incubated
with pyruvate previous to cinnamaldehyde mixing than when SbAD is by itself or combined with
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cinnamaldehyde

before

pyruvate

addition, suggesting that it is more
efficient to have pyruvate bound first,
before cinnamaldehyde. The reaction of
SbAD with CMP and SbAD mixed against
pyruvate and cinnamaldehyde had the
about the same kobs,1, showing that the
Scheme 8. Inhibitors tested for SbAD.

reversibility of SbAD occurs on a similar
time scale. Interestingly, the turnover number for steady state kinetics at room temperature was
28.3 ± 0.4 sec-1 in 50 mM BIS-Tris pH 6.5, whereas the stopped flow values were recorded at 5 °C
in the same buffer, but at pH 7.0. Temperature has an effect on the reaction rate, the discrepancy
in rates from temperature likely has to do with steady state being the culmination of all steps in
the reaction, whereas single turnover is recorded for transient species. Overall, the synthetic
direction with incubated pyruvate provides the reaction with a kobs of 65 sec-1, and about 45 sec1

if SbAD is alone, then mixed with substrates, or if SbAD is incubated with cinnamaldehyde

before reacting with pyruvate. The retro-aldol
breakdown is about 45 sec-1 as well.

Table 6. KD values for cinnamaldehyde (1) and
pyruvate (2), compared to substrate analogs 4-7 as
determined by fluorescence titration.
Compound
KD
Cinnamaldehyde (1)

58.18 ± 6.74 µM

4-phenyl-3-buten-2-one (7)

42.34 ± 12.78 µM

Pyruvate (2)

6.48 ± 0.59 mM

efficient if bound first, it didn’t answer the question

2,3-butanedione (4)

12.24 ± 1.67 mM

of whether or not pyruvate has to bind first for a

Oxamate (5)

97.04 ± 10.60 mM

Glyoxylate (6)

> 500 mM

Though the single turnover order of
addition kinetics hinted that pyruvate may be more

reaction to occur with SbAD. Inhibition kinetics
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addressed this question by competing substrate analogs with pyruvate and cinnamaldehyde. The
candidate substrates are shown in Scheme 8, and KD values in Table 6. The substrate analog for
cinnamaldehyde (1) was 4-phenyl-3-buten-2-one (7), as the nucleophilic attack by the pyruvate
enamine on the ketone of 7 cannot occur due to the added bulk of the methyl group. Other
options for sodium pyruvate were available, however 2,3-butanedione (4) had the most similar
binding constant. This suggests that the methyl group of pyruvate may also be important to
binding. The best inhibition models and the associated Ki values are given in Table 7.
Table 7. Inhibition kinetics were used determine the order of addition of pyruvate and cinnamaldehyde in the active site of
SbAD.
Compound of interest
Varying inhibitor
Inhibition model
Ki
pyruvate

2,3-butanedione

Non-competitive

36.38 ± 2.45 mM

cinnamaldehyde

2,3-butanedione

Mixed

8.12 ± 1.66 mM

pyruvate

4-phenyl-3-buten-2-one

No Effect

‒

cinnamaldehyde

4-phenyl-3-buten-2-one

Competitive

258.6 ± 77.39 µM

Based on Table 7, it appears that pyruvate likely binds first, as 4-phenyl-3-buten-2-one has no
effect on catalysis when pyruvate is varied. In addition, pyruvate was surprisingly noncompetitive with 2,3-butanedione, suggesting that although cinnamaldehyde or 2,3-butanedione
may already be in the active site, pyruvate is still able to bind. Cinnamaldehyde was competitive
with 7, which shows that after pyruvate is bound, the aldehyde acceptor is needed next for
catalysis, consistent with the proposed mechanism.
Kinetic isotope effects were also done to tease apart the mechanism of SbAD. 1H3
pyruvate and 2H3 pyruvate were observed via single turnover to see the effect deuterated
substrate had on the transient kinetics with cinnamaldehyde going in the synthetic direction to
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form cinnamylidenepyruvate (CMP). The data are shown in Figure 24, where the end points have

Figure 24. KIE of 1H3 and 2H3 of pyruvate, where 1H3 is in green with a dashed fit line, and 2H3 is in blue with a solid fit line.
Underneath are the kobs associated with 360 and 430 nm.

been artificially moved to match one another for comparison purposes. The data at 360nm for
1H
3

(Figure 24 A, green) is best modeled by a two exponential fit, whereas the data with 2H3

(Figure 24 A, blue) shows a lag, and then appears to speed up such that only the second kobs from
1H
3

is comparable. These results are consistent with a secondary, inverse effect, consistent with

the proposed mechanism where the enamine goes from sp2 to sp3 during nucleophilic attack on
the aldehyde substrate. The 430 nm data (Figure 24 B), however, show a primary effect, as the
rates for 2H3 (Figure 24 B, blue) are slower in kobs,1 and kobs,2. The fits do not agree well with the
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data for 2H3 pyruvate (Figure 24 B, blue), suggesting that there is more going than can be modeled
by a simple two exponential equation.
In addition to transient kinetics, steady state kinetics were also done with KIE. First, the
reaction of 1 and 2H3 pyruvate in the synthetic direction was studied to see if there would be any
Table 8. Steady state kinetics comparing saturating 1H3 and 2H3
pyruvate with cinnamaldehyde, monitored at 360 nm at 25 °C.
Reactions were done in triplicate.
1H pyruvate
2H pyruvate
3
3

difference in the steady state rates, Table 8.

kcat,cinn (sec-1)

9.0 ± 1.1

10.4 ± 1.0

not surprising, as the steady state rate is all

KM,cinn (µM)

23.0 ± 8.1

40.1 ± 6.6

of the accrued steps in the reaction. In the

kcat,cinn/KM,cinn

(M-1sec-1)

3.9 x

105

2.6 x

The values are largely equivalent, which is
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transient kinetic experiments, after 1
second, largely equivalent kobs are obtained. We also analyzed the reaction for a solvent isotope
effect. Phosphate buffer was used, as it could be controlled for pH via the Henderson-Hasselbalch
equation rather than titrated to pH with deuterated HCl or NaOH. The results for the reaction in
the catabolic direction, of 3 going to 1 and 2, in proteo- and deutero buffer are seen in Table 9.
In this preliminary experiment, the kcat shows a clear difference between the reaction rates
between the proteo and deuterated solvent, suggesting the importance of water in the retroaldol cleavage reaction.

Table 9. Steady state kinetics comparing saturating 1H and 2H phosphate buffer with
CMP catalysis, monitored at 360 nm at 25 °C. Reactions were done in triplicate.
1H 50 mM PO pH 7.0
2H 50 mM PO pD 7.4
4
4
kcat,cinn (sec-1)

0.35 ± 0.01

0.06 ± 0.001

KM,cinn (µM)

18.8 ± 2.5

14.3 ± 1.4

kcat,cinn/KM,cinn (M-1sec-1)

1.9 x 104

4.2 x 103
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Another important component of
elucidating the mechanism of SbAD has been
mutant analysis. Point

mutations were

generated at select positions within the active
site,

then

characterized

these

SbAD

by

steady

variants
state

were

kinetics,

fluorescence titration of substrates to test
effects on binding, and X-ray crystallography.
Figure 25 illustrates the residues that were
mutated in the active site. We hypothesized

Figure 25. Active site residues of interest that were mutated
to observe the effect of steady state kinetics. This is the
active site pyruvate-bound structure seen in Chapter II.

that a change of Try82, a component of the

carboxylate binding site, would decrease kcat and increase KM, as it does contribute a potential
hydrogen bonding interaction to the pyruvate carboxylate group. We also hypothesized that
mutating the active site lysine would result in an inactive enzyme. Likewise, if Glu84 is the only
acid/base catalyst, there should be no activity if it is mutated to a residue that cannot play this
role. Tyr252 was the residue bound to the same conserved water in both the formate- and
pyruvate-bound structures. We postulated that Tyr252 might be involved in binding the incoming
aldehyde substrate and/or orienting it for attack by the enamine. Mutating Tyr252 to Phe
removes any potential non-covalent interaction with the aldehyde and should have a noticeable
effect on catalysis. Lastly, Gln118 was mutated to Asn. Another Family V enzyme, Swit_4259
(Swit; see Chapter V), naturally has Asn at this position, and appears differ from SbAD in terms of
its function. We speculated that mutating Gln118 to Asn would result in an SbAD variant that
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Table 10. Steady state kinetics for active site mutants of SbAD at 25°C.
SbAD

kcat,cinnamaldehyde (sec-1)

KM,cinnamaldehyde (µM)

kcat/KM (M-1 sec-1)

WT

23.00 ± 0.38

38.43 ± 2.03

5.98 ± 0.33 x 105

E84Q

2.52 ± 0.02

38.88 ± 1.10

6.48 ± 0.19 x 104

Q118N

0.214 ± 0.006

52.86 ± 5.20

4.05 ± 0.41 x 103

K122M

No Activity

Y252F

1.45 ± 0.01

5.42 ± 0.67

2.67 ± 0.33 x 105

Y82F Y252F

1.20 ± 0.02

7.22 ± 0.75

1.66 ± 0.17 x 105

E84Q Y252F

No Activity

behaved more like Swit. Double mutants were also created in an effort to detect cooperative
residues. Tyr82Phe/Tyr252Phe and Tyr82Phe/Glu84Gln could affect binding and catalysis. If that
is the case for the double mutants, the steady state kinetics should have lower kcat and higher KM
than the individual mutants. Glu84Gln/Tyr252Phe was based on two possible key catalytic
residues in the active site, and are predicted to render the enzyme inactive if they are both
needed for catalysis. The effects of the mutations on the steady state parameters and relevant
binding constant(s) in the synthetic direction with cinnamaldehyde and pyruvate are given in
Table 10 and 11, respectively. All

Table 11. KD values for SbAD WT and active site mutants
SbAD

experiments were performed

Sodium Pyruvate (mM)

Cinnamaldehyde (µM)

WT

6.48 ± 0.59

58.18 ± 6.74

Y82F

1.87 ± 0.27

81.83 ± 8.72

(50 mM) at 25 °C. It is clear from

E84Q

5.28 ± 1.06

56.58 ± 3.24

Table 10 that Glu84 is not the

Q118N

5.36 ± 1.01

73.89 ± 6.66

K122M

11.29 ± 1.79

87.29 ± 9.57

Y252F

5.50 ± 0.86

41.74 ± 2.98

E84Q Y252F

54.69 ± 5.99

93.24 ± 9.25

with near-saturating pyruvate

sole acid/base catalyst, as there
is only a 10-fold reduction in
activity in the Glu84Gln mutant.
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Table 12. Comparison of SbAD WT and Y82F in steady state kinetics at 4 °C with
4-nitrocinnamaldehyde (4NC) and 4-nitrocinnamylidenepyruvate (4NCP).
SbAD WT
SbAD Y82F
kcat,4NC (sec-1)

6.3 ± 0.1

13.9 ± 0.3

KM,4NC (µM)

2.9 ± 0.7

11.8 ± 1.0

kcat/KM,4NC (M-1 sec-1)

2.2 ± 0.5 x 106

1.2 ± 0.1 x 106

kcat,4NCP (sec-1)

1.9 ± 0.5

1.9 ± 0.2

KM,4NCP (µM)

82.3 ± 29.1

75.1 ± 9.2

kcat/KM,4NCP

(M-1

sec-1)

2.3 ± 1.0 x

104

2.5 ± 0.4 x

The Glu118Asn shows a dramatic
decrease in kcat, while the KM is
largely unaffected, suggesting
that is plays a catalytic role, at
least indirectly, and is not there
solely for substrate binding. As
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expected, Lys122Met had no
activity because there is no amine available for the Schiff base chemistry. The Tyr252Phe variant
exhibited a tighter KM than WT, however its kcat was slower. This may be due to the inability to
properly orient the aldehyde group for catalysis. All of the values are from steady state kinetics,
however, which do not articulate if the activity is due to binding or catalysis. Tyr82Phe was not
shown in Table 10 because it was measured with different substrates and at a different
temperature. Table 12 compares WT and Tyr82Phe reacting with 50 mM pyruvate and varying
concentrations of 4-nitrocinnamaldehyde at 4°C in 100 mM MOPS pH 7.0. The values for the
reverse reaction, breakdown of 4-nitrocinnamylidenepyruvate (4NCP) under the same conditions
Table 13. Steady state kinetics for active site mutants of SbAD in the catabolic direction.
SbAD

kcat,CMP (sec-1)

KM,CMP (µM)

kcat/KM (M-1 sec-1)

WT

1.14 ± 0.05

15.42 ± 1.95

7.39 ± 0.99 x 104

E84Q

0.56 ± 0.02

27.13 ± 1.91

2.06 ± 0.16 x 104

Q118N

0.37 ± 0.03

16.57 ± 3.33

2.23 ± 0.48 x 104

K122M

No Activity

Y252F

0.74 ± 0.02

4.82 ± 0.43

1.53 ± 0.14 x 105

Y82F Y252F

0.53 ± 0.04

26.42 ± 4.56

2.0 ± 0.38 x 104

E84Q Y252F

No Activity
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are also given. The Tyr82Phe mutant and WT SbAD are almost identical. It appears that Y82 is not
a necessary part of the carboxylate-binding site, and it plays no discernable catalytic role. Table
13, the breakdown direction of cinnamylidenepyruvate (CMP) 3, the mutants largely follow SbAD
WT. Either the loss of conjugation at 360 nm is occurring from the complete breakdown of 3, or
it could be that 3 has bound to the enzyme, lost conjugation, but cannot complete the catabolic
process.
The KD values of cinnamaldehyde and pyruvate were measured to more fully understand
mutations upon substrate binding (Table 11). Based on the activity of Gln118Asn, it was proposed
that the lack of activity was to do impairment of substrate binding. However, the binding
constants for both pyruvate and cinnamaldehyde are identical. Therefore, Gln118Asn may play a
catalytic role, perhaps keeping the substrate carboxylate for substrate assisted catalysis, similar
to sialic acid aldolase, mentioned in Chapter II

32.

Alternatively, Glu118 might keep another

catalytic residue in position for catalysis. The mutants with no activity in steady state kinetics also
have KD values essentially identical to WT. The KD of Lys122Met has only about doubled in value,
suggesting that the carboxylate-binding site is responsible for the bulk of pyruvate binding, at
least, and that the measured values are not dominated by the covalent attachment to Lys122. In
the Glu84Asn/Tyr252Phe double mutant, the KD for pyruvate is nearly 10-fold higher, though the
KD for cinnamaldehyde is about the same. The KD for 4NCP is not in Table 11 because Lys122Met
was used to prevent catalysis from occurring. 4NCP with Lys122Met was 14.44 ± 3.52 µM.
Lys122Met was a reliable source to approximate KD as its values with pyruvate an
cinnamaldehyde resembles SbAD WT.
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Most of the kinetics were done between pH 6.5 and 7.0, however a formal pH rate profile
remained to be done. The goal was to find approximate pKas for the active site residues that
could be participating in the reaction. The results for the WT enzyme are shown in Figure 26 A.
The results from fitting WT were pKas of 4.09 and 8.95. The fit does not represent what has been
measured, indicating that there are more complex reactions going on than simple proton
transfer. The 4.09 pKa indicated that perhaps the Glu84 mutant was the largely responsible
acid/base catalyst, so Glu84Gln also had the pH rate profile done. The pKas from Glu84Gln were
4.37 and 7.89. It was expected to show different activity if E84 was the only acid/base catalyst,
but the fit looks like WT, thereby concluding again that there are more complicated reactions
occurring than a pH rate profile can answer.

Figure 26. pH rate profile for SbAD WT (A) and SbAD E84Q (B). Both follow the same overall shape from fitting, concluding
that E84 is not the sole acid/base catalyst in the reaction, but does indeed react more slowly than WT.

During the mutagenesis process, it was proposed that E84Q could be impaired due to
perturbation of the structure. Therefore, DSC was done to test the stability of this mutant (Figure
27).
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Figure 27. DSC for WT and E84Q. The raw data is compared to the van’t Hoft analysis.

Table 14. Results and analysis of DSC for SbAD WT and active site mutant, where ΔHvH is the van’t Hoff analysis.
SbAD
Tm (°C)
ΔH (kJ mol-1)
ΔS (kJ mol-1 K-1)
ΔHvH (kJ mol-1)
WT

53.4 ± 0.6

241.2 ± 37.0

0.74 ± 0.1

654.3 ± 55.1

E84Q

45.4 ± 0.1

62.2 ± 6.0

0.20 ± 0.0

666.8 ± 11.2

A clear difference is seen for the Tm of Glu84Gln compared to WT, as seen in Table 14. Since the
ΔH° values derived from DSC are smaller than the van’t Hoff analysis within the error estimates,
it appears that there is a two-state transition between folded and unfolded SbAD. There is no
information based on ΔHvH to determine if the proteins formed oligomers before aggregation or
intermediates on the way to unfolding.
All of the values quoted thus far are from
steady state kinetics, however, which makes it
difficult to confidently assess each residue’s role in
SbAD catalysis. Select active site mutants were
looked at by transient kinetics under single
Figure 28. 50 µM 4NCP reacted with 10 µM SbAD WT,
Y252F, and E84Q in 50 mM BIS-Tris pH 6.5, 5 °C.

turnover conditions. At 430 nm (Figure 28), it is
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apparent that, while the intermediate begins to decay in the WT enzyme by about 100
milliseconds, it remains stable in Tyr252Phe well past 1 second (see Appendix). The Glu84Gln
mutant appears to be completely dead on this time scale, but the reaction is occurring as
evidenced by the steady state kinetics (see above). The stability of the proposed Schiff base
intermediate in the Tyr252 active site suggested that it would be a good candidate for
crystallization.
Table 15. Crystallographic Data Collection and Model Refinement Statistics.
SbAD Y252F·4NCP
resolution (Å) (last shell)a
completeness (%)a
Rmerge (%)a,b
multiplicity
⟨I/σ(I)⟩a

50.00-1.90 (1.97-1.90)
99.8 (99.4)
0.110 (0.494)
19.8 (4.0)
7.0 (6.0)
Model Refinement

Rcryst (Rfree)
0.166 (0.192)
average B factor (Å2)c
protein atoms
22.2
solvent
32.9
root-mean-square deviation
bond lengths (Å)
0.005
bond angles (deg)
0.953
Ramachandran statistics
(favored/allowed/outliers)
98.2/1.8/0
aValues in parentheses apply to the high-resolution shell indicated in the resolution row.
bR = ∑(||F | − scale ×| F
c
obs
calc||)/∑|Fobs|. Isotropic equivalent B factors, including the
contribution from TLS reﬁnement.

The condensation product was trapped in all four active sites, with waters excluded from
the active site tunnel, as seen in Figure 29. The red loop marks the surface of the protein, and
mouth of the active site. On either side of the active site loop, there are two openings to this
narrow, funnel-shaped active site, and the Tyr252Phe mutant is visible (red label in Figure 29).
Aside from the carboxylate-binding site, the rest of the active site is hydrophobic and binding of
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Figure 29. Crystal structure of SbAD Y252F with 4NCP bound in the active site. 2|Fo|-|Fc| electron density is in magenta
and SA omit electron density is in green. Both are contoured at 1.2σ.

the product is ruled by Van der Waal interactions. It may be that this complex is trapped because
there is no hydrogen bonding group or water to facilitate hydration of the double bond. Thus,
Tyr252 would appear to have a catalytic role. The torsion angles of the bound product (Figure 30
and Table 16) are also intriguing.
Table 16. Values of the dihedral were averaged over the four
active sites in the crystallographic asymmetric unit.
Torsion angles
Average (degrees)
Range (degrees)

6

4
5
3

1

169.9 ± 3.0

166.4 – 173.3

2

163.7 ± 5.1

156.2 – 167.8

3

164.8 ± 2.8

161.6 – 167.9

4

82.4 ± 12.8

72.2 – 100.5

5

175.2 ± 2.5

171.5 – 176.8

6

34.4 ± 13.1

19.1 – 48.0

2
1

Figure 30. Torsion angles of the 4NCP complex.
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The torsion angle labeled as 4 is near 90 °, suggesting that it contributes to substrate
destabilization by breaking up the conjugation from the ring system, and making it easier to add
water across the double bond that would lead to an aldol intermediate before retro-aldol
cleavage. The Schiff base complex with 4NCP is the intermediate thought to be seen at 430nm.
If the conjugation is broken like this when the protein is in solution, then this Schiff base should
not be seen spectroscopically.

Figure 31. Size exclusion results. Each trace has been artificially shifted by 100 mAu for clarity.

In addition to active site mutants, protomer interface mutants were also explored. They
were initially predicted to have perturbed pKa values due to Theoretical Microscopic Titration
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Curves (THEMATICS) and Partial Order Optimum Likelihood (POOL) analysis 33. THEMATICS uses
the sequence of a protein in a crystal structure to search for ionizable residues, along with the
probability that a residue participates in binding or catalysis from POOL to determine
hypothetical pKas. The program accurately predicted the perturbed Lys122 in the active site,
however it also suggested Asp107 and Asp109 also have perturbed pKa values. As a means to
explore this possibility, Asp107 was mutated to Asn, and Asp109 to Asn and Ala. All three mutants
were analyzed by gel filtration, which indicated the presence of significant aggregation (Figure
31). All mutants and WT were produced, then incubated at 4 °C for 24 hours before gel filtration
analysis. The Asp109Asn variant showed multiple peaks in the chromatogram, indicating that it
exists as aggregate, as well as a mixture of other oligomeric states. The molecular weight of the
species in the first peak was estimated to be 74.6 kDa, between a dimer and trimer, while the
second peak appears to be a dimer. Attempts were made to determine the structure of the
Asp109Asn variant, however the crystals were poor and did not diffract well enough.
Characterization of Asp109Asn by DSC shows that it is much less stable than WT and Glu84Gln
(Figure 31).
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Table 17. Results and analysis of DSC for SbAD WT and protomer mutant, where ΔHvH is the van’t Hoff analysis.
SbAD
Tm (°C)
ΔH (kJ mol-1)
ΔS (kJ mol-1 K-1)
ΔHvH (kJ mol-1)
WT

53.4 ± 0.6

241.2 ± 37.0

0.74 ± 0.1

654.3 ± 55.1

D109N

39.6 ± 0.5

54.5 ± 10.2

0.17 ± 0.0

709.1 ± 137.8

Again, the van’t Hoff analysis is larger, within error, of the calculated of ΔH as determined by
experiment, suggesting a simplified two-state model of either the protein is folded, or not. The
steady state kinetics and selected binding constants shed light on to the instability. Table 18
compares the steady state kinetics of the protomer mutants with cinnamaldehyde (1) and
saturating pyruvate (2) compared to WT, as well as the breakdown of cinnamylidenepyruvate (3).
Asp107Asn surprisingly had a higher turnover number than WT. It is not entirely clear why this
is, as modeling in Asn at the 107 position does not appear to disturb the hydrogen bonding
distances. Asp109Ala, and more to Asp109Asn, have slower kcat and bigger KM in the synthetic
direction, possibly due to a slight possible conformational shift.
Table 18. The anabolic and catabolic steady state kinetics of protomer interface mutants.
kcat/KM (M-1 sec-1)

kcat,CMP (sec-1)

KM,CMP (µM)

kcat/KM (M-1 sec-1)

38.43 ± 2.03

5.98 ± 0.33 x 105

1.14 ± 0.05

15.42 ± 1.95

7.39 ± 0.99 x 104

47.89 ± 0.81

27.62 ± 1.67

1.73 ± 0.11 x 106

1.82 ± 0.03

11.44 ± 0.66

1.59 ± 0.10 x 105

D109A

5.86 ± 0.12

56.15 ± 3.29

1.04 ± 0.06 x 105

0.64 ± 0.03

19.70 ± 2.54

3.25 ± 0.45 x 104

D109N

0.151 ± 0.006

11.09 ± 2.19

1.36 ± 0.27 x 104

0.33 ± 0.02

11.98 ± 1.68

2.75 ± 0.04 x 104

SbAD

kcat,cinnamaldehyde

KM,cinnamaldehyde

(sec-1)

(µM)

WT

23.00 ± 0.38

D107N

Asp109Ala behaves much like WT, the truncated residue does not greatly affect its steady state
values. Overall, Table 18 indicates that the protomer mutant Asp109Asn is an inactive protein,
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such that the concentration of active enzyme is much less than the concentration of the total
enzyme since the KM values are equivalent to WT, and kcat is slower than WT.

4.4 Conclusions
The proposed mechanism of Figure 20 has been confirmed throughout this chapter as a
likely method of catalysis. Pyruvate binds to the enzyme first, for a sequential, ordered reaction.
An imine with pyruvate and the active site lysine, then attacks the aldehyde carbon from the
nucleophilic enamine. The Schiff base with product bound is proposed to be observed at 430nm,
however the crystallographic data from Tyr252Phe suggests the break in conjugation with the
ring system would result in lack in observable absorbance at that longer wavelength. It is possible
torsion aids breakdown in the retro-aldol process, and was slow enough to occur from the mutant
that it was able to be trapped. Hydrolysis of product from the enzyme is likely to be rate limiting
based on the burst kinetics and single turnover work. The protomer interface mutants show
structural instability and do not point to cooperativity in the enzyme. SbAD demonstrates
aldolase-dehydratase ability with the ADC overall fold, and illustrates the subtle differences
between true ADCs and MppR by catalyzing different reactions, but still retaining a Schiff base
mechanism.
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CHAPTER V: STRUCTURAL AND FUNCTIONAL ANALYSIS OF SWIT_4259
5.1 Introduction
Some of the most dangerous and wide-spread pollutants on earth are aromatic
hydrocarbons like dioxins, polychlorinated biphenyls (PCBs), herbicides, and pesticides. These
compounds are recalcitrant in the environment due to their low solubility in water, tendency to
adsorb to solids, and dissimilarity to naturally occurring compounds (e.g. halogenation). Thus,
there is significant interest in natural or engineered bioremediation pathways capable of
metabolizing these contaminants to harmless organic compounds 1. Some microorganisms,
particularly bacteria, have evolved the ability to consume aromatic hydrocarbons as carbon and
energy sources

2-4.

Sphingomonas wittichii RW1 is a Gram-negative bacterium that was first

isolated from contaminated sediments in the Elbe River in Germany, and it is known for its ability
to degrade a wide variety of aromatic substrates, including dioxins and PCBs 5, 6. The S. wittichii
RW1 genome thus contains a large number of aromatic hydrocarbon catabolism gene clusters,
only a handful of which have been characterized.
Relative to other species, the S. wittichii genome is enriched for TonB-dependent
receptors (TDRs; COG1629), dehydrogenases (COG1028), and phenylpropionate dioxygenases
(COG4638) 7. In fact, the S. wittichii RW1 genome contains the most TonB-dependent receptors
of any genome sequenced to date 8. This is interesting, because the TonB system is normally
associated with uptake of iron-bound siderophores, but the majority of TDR genes in S. wittichii
RW1 are not in operons associated with iron transport. TonB-dependent receptors have been
implicated in the transport of other compounds, including sugars 9, alginate
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10,

and aromatic

hydrocarbons (AH) 11. This strongly suggests that many of the TDR-containing gene clusters in S.
wittichii may actually be cryptic AH-degrading operons.

Figure 33. Gene context of S. wittichii Swit_4259.

One of these TDR-containing, putative AH-degrading gene clusters in S. wittichii (Figure
33) is particularly interesting for its inclusion of an acetoacetate decarboxylase-like enzyme,
Swit_4259. Swit_4259 (SwADC) has 18% sequence identity to the prototypical Clostridium
acetobutylicum acetoacetate decarboxylase (AAB53232), placing it in the acetoacetate
decarboxylase-like superfamily (ADCSF). The ADCSF is a poorly-characterized group of enzymes
with significant diversity in both substrate and reaction specificities

12.

The characterized

acetoacetate decarboxylases (e.g. the C. acetobutylicum enzyme) comprise the majority of
ADCSF sequences and are designated Family I. The reactive lysine residue that forms a Schiff base
intermediate is conserved in all but one ADCSF family (Family II). SwADC belongs to ADCSF Family
V, whose members, based on gene context, are primarily involved in secondary metabolism..
MppR from Streptomyces hygroscopicus

13

was shown to catalyze both aldol condensation

followed by dehydration of pyruvate and imidazole-4-carboxaldehyde as well as cyclization of 4hydroxy-2-keto arginine to produce 2-keto-enduracididine 12, as seen in chapter II, though it is
not known if these activities are physiologically relevant. Herein we describe the tertiary
structure of SwADC as well as a preliminary characterization of its enzymatic activity.
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5.2 Materials and Methods
Cloning, expression, and purification of SwADC.
The gene at locus Swit_4259 encoding the protein identified by GenBank accession code
YP_001264737 7 was optimized for expression in E. coli and synthesized by GenScript (Piscataway,
NJ). The SwADC gene was amplified using oligonuculeotide primers SwADC-pSUf (5’GGTCTCAAGGTATGGCTGGTGCTACGCAT-3’), which introduces a Bsa I site, and SwADC-pSUr (5’GCTCTAGATCATCACATACGCAGGGATTCCA-3’), which introduces a stop codon and Xba I site.
Purified PCR products were digested with Bsa I and Xba I and ligated into the pE-SUMOkan
expression vector (LifeSensors Inc, Malvern, PA) to generate pSUMO-SwADC. This plasmid
expresses SwADC with His6-tagged small ubiquitin-like modifier (SUMO) fused to the N-terminus
14.

The sequence of pSUMO-SwADC was confirmed by sequencing (GenWiz Inc). BL21 Star (DE3)

E. coli cells (Invitrogen) were transformed with pSUMO-SwADC and used to inoculate 20 ml
cultures of Luria-Bertani broth supplemented with 50 μg/mL kanamycin. These starter cultures
were grown overnight at 37 °C with agitation at 250 rpm. Large-scale cultures (1 L) were
inoculated from the starter cultures and grown at 37 °C/225 rpm until they reached an OD 600 nm
of about 1.0. The temperature of the incubator was reduced to 25 °C and expression of SwADC
was induced by addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration
of 400 µM. Cultures were grown overnight at 25 °C. Cells were harvested from the expression
culture by centrifugation at 7400  g for 30 min and resuspended in Buffer A (25 mM Tris, pH 8.0,
300 mM NaCl, and 10 mM imidazole) at a rate of 5 mL of buffer per gram of cell pellet. Lysozyme
was added to a final concentration of 1 mg/mL and the mixture was stored overnight at −20
°C. The cell suspension was thawed at RT and allowed to stand for 2 hours, after which
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deoxyribonuclease I (DNase I, Worthington Biochemical Inc.) was added at a rate of 0.5 mg per
100 ml of lysate. The lysate was clarified by centrifugation at 39000  g for 45 min.
Immobilized metal affinity chromatography (IMAC) purification of SwADC was performed in
two steps. The clarified lysate was applied to a 5 mL HisTrap column (GE Life Sciences, USA) and
eluted using a 4-step gradient from 0 to 5, 15, 50, and 100% Buffer B (25 mM Tris, pH 8.0, 300
mM NaCl, and 250 mM imidazole). SwADC eluted primarily at 50% Buffer B (about 125 mM
imidazole), but a significant amount eluted at the 100% Buffer B step (about 250 mM imidazole).
The fractions from both elution peaks containing SwADC, as judged by Coomassie-stained SDSPAGE gels, were pooled. SUMO protease (LifeSensors Inc) was added to a final concentration of
about 5 μM

15.

The pooled eluate was dialyzed overnight at 4 °C in Buffer C (25 mM Tris, pH 8.0,

150 mM NaCl) to remove imidazole. In the second step of the purification, the same HisTrap
column was used to remove the cleaved His6-SUMO fusion partner and the His6-tagged SUMO
protease. The resulting protein was > 95% pure as judged by SDS-PAGE. A 10 mL HiTrapDesalting
column (GE Life Sciences, USA) was used to exchange the buffer to 25 mM Bis-Tris pH 7.1 (titrated
with saturated iminodiacetic acid). The concentration of SwADC was estimated by the
absorbance at 280 nm (ε280 = 46,660 M-1cm-1). The final yield of purified SwADC was
approximately 15 mg per L of culture.

Size exclusion chromatography.
The solution molecular weight of SwADC was estimated by gel filtration chromatography
using a BioBasic SEC-300 (250mm  4.6 mm) column (Thermo Scientific, USA) on an Agilent 1220
Compact LC. The mobile phase consisted of 25 mM Tris, pH 8.0, 300 mM NaCl at a flow rate of
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0.5 ml/min with UV-Vis detection at 280 nm. The column was calibrated using standard proteins
including equine heart cytochrome C (12.4 kDa), bovine erythrocyte carbonic anhydrase (29 kDa),
bovine serum albumin (66 kDa), yeast alcohol dehydrogenase (150 kDa), and sweet potato –
amylase (200 kDa). To define the standard curve, each protein was dissolved at 10 mg/mL in the
running buffer and the separation was performed on 250 μL of the standard mixture at 25 °C. A
sample of SwADC (6 mg/mL) was run immediately afterward using the same column and identical
conditions.

Crystallization, data collection and structure determination.
Preliminary crystallization conditions were identified by sparse matrix screening using the
Index HT, PEG/Ion HT, and PEGRx HT screens (Hampton Research, USA) at 21 °C. Crystals
appeared after 1 to 2 days in a variety of conditions. The initial crystals ranged in shape from
individual rods to what appeared to be bundles of parallel needles. The single, rod-shaped
crystals diffracted very poorly (dmin ~5 Å), but the "bundles of rods" diffracted to a maximum
resolution of ~2.0 Å. Diffraction-quality crystals were grown by the hanging-drop vapor diffusion
method. Drops were formed by mixing 1-2 μl of SwADC (37 mg/ml) in 20 mM phosphate pH 7.0
with 1 μl of well solution containing 15 % PEG 3,350 and 0.1-0.2M magnesium formate. Crystals
were flash-cooled by plunging them in liquid nitrogen, without a cryoprotectant. Diffraction data
were collected from an SwADC crystal at the Life Sciences-Collaborative Access Team, beamline
21-ID-G equipped with a MAR 300 CCD detector, 50 x 50 µm beam at a wavelength of 0.97857 Å.
A total of 440 frames were collected from ω = 150 ° to 370 ° with an oscillation range of 0.5 °.
Diffraction data were integrated and scaled using MOSFLM 16, 17 and SCALA 18 as implemented in
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the CCP4 suite version 6.3 19. Initial phases were obtained by molecular replacement in PHASER
20

using the structure of the related ADCSF enzyme MppR (PDB ID 4JM3) as the starting model.

Iterative rounds of model building and refinement were performed using PHENIX 21, 22 and COOT
23, 24.

Structures were validated using the tools available in the PHENIX package

25, 26.

The data

processing and model refinement statistics are summarized in Table 19.

Acetoacetate decarboxylase activity assay.
SwADC was assayed for acetoacetate decarboxylase activity by monitoring the disappearance
of the enolate form of acetoacetate spectrophotometrically at 270 nm (Δε = 24.6 M-1 cm-1) as
described 27. Reactions were run at 25 °C in 50 mM phosphate buffer, pH 6.5, 2 mM EDTA, on a
Thermo Scientific Evolution 300 spectrophotometer. The reaction mix containing 20 mM lithium
acetoacetate in the assay buffer was used as the blank. The reaction was initiated by the addition
of 10 μM SwADC in the same buffer.

Determination of binding constants.
There is one tryptophan (Trp24) in the active-site pocket close to Lys122 (about 7 Å between
Nε of Lys122 and the indole ring of Trp24) which is sensitive to the binding of small molecules in
the active site. Potential substrates can be titrated to determine the dissociation constant (KD) of
each compound. The affinity of SwADC for a number of α-keto-acids such as pyruvate and α–keto
glutarate was tested. Alanine was used as a control compound since it cannot react with the
active site lysine. The fluorescence signal of Trp excited at 280nm was monitored using TgK
Scientific stopped flow with 20 μM SwADC or Hitachi F-4500 fluorimeter with 5 µM SwADC and
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varied substrate concentrations ranging from 1 mM to 1 M, all in in 100 mM Bis-Tris pH 6.5. The
change in fluorescence signal was also tested using 2-oxo-adipic acid only in 5 mM concentration
owing to the expense of the compound.

Production of 2-hydroxymuconic acid (2HM) (Scheme 9, 1)
The synthesis of 2-hydroxymuconic acid was based on that of Metanis et al 28. A solution of
t-BuOK was prepared by dissolving potassium metal (1.92 g) in t-BuOH (20 mL) and refluxing until
homogenous. Then, 8 mL of the t-BuOK solution (excess) was combined with 2 mL of ether and
stirred at 0° C for 15 minutes. A solution of diethyl oxalate was made by mixing 1.35 mL of diethyl
oxalate and 1 mL of ether. This solution was cooled to 0 °C and added to the t-BuOK solution via
syringe. The reaction mixture was allowed to stir for another 15 minutes. A solution of ethyl
crotonate was made by mixing 1.2 mL of ethyl crotonate with 1 mL ether. This solution was
cooled to 0° C and added via syringe. The mixture was allowed to stir for 30 minutes and then
placed stored at 4° C overnight to precipitate the potassium salt. Potassium salt was filtered and
rinsed with hexanes and dried under vacuum to yield 1.907 g of the potassium salt. The
potassium salt was dissolved in 25 mL DI H2O and 1 mL of glacial acetic acid was added. Resulting
precipitate was collected by filtration and dried under vacuum to yield 1.3209 g of the diester.
The diester was dissolved in a NaOH solution (2 M, 20 mL) and left at room temperature
overnight. The solution was then acidified to pH 2 with HCl (12 M) and then placed on an ice bath
for 1 hour. Precipitate was collected by filtration and dried under vacuum to yield 339.5 mg of
diacid.
Preparation of 3-(2-furyl)acrolenepyruvate (Chapter III, Scheme 4, 22)
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The compound was synthesized as described in Chapter III.
Steady-state kinetics and product identification.
Based on our hypothesis that SwADC is an aldolase-dehydratase acting in an uncharacterized
hydrocarbon degradation pathway, the activity of SwADC was tested with potential substrates
including 2-oxo-3-hexenedioate (OHD), and 3-(2-furyl)acrolein and pyruvate. The assays were
performed with 0.5 – 1 μM SwADC in 50 mM BIS-Tris pH 6.5, and various substrate
concentrations. In aldol condensation reactions, sodium pyruvate was saturating (50 mM)
The enzyme 4-oxalocrotonate tautomerase (4-OT) was used to produce OHD from 2-hydroxy
muconic acid (2HM). Reactions contained 50 mM sodium phosphate buffer pH 6.5, 1 μM 4-OT,
and 100 μM 2HM in a final volume of 0.5 ml. The production of 2-oxo-3-hexenedioate was
monitored at 236 nm (ε = 6580 M-1 cm-1) or in UV-Vis spectra from 220 to 340 nm. Each assay
was incubated without SwADC until the absorbance at 236 nm reached a maximum. At this point,
SwADC was added to the mixture and the loss of absorbance at 236 nm was monitored. The assay
was performed with 100 μM 2HM and different concentrations of SwADC (1, 2, or 4 μM). The
assay also was performed using 5 μM SwADC and concentrations of 2HM ranging from 0 to 200
μM. The activities of the K122A, K122M, and Y120F variants were tested using the same protocol.

5.3 Results and Discussion
Overall structure of SwADC.
SwADC is a 28.8 kDa protein that, according to size exclusion chromatography, exists as a
homotetramer in solution. The protein crystallized from 15% PEG 3,350 and 0.1 ‒ 0.2M
magnesium formate, forming long, hexagonal rods on the order of 0.5 x 0.05 x 0.05 mm. These
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crystals diffracted X-rays to ~2.0 Å-resolution. Numerous, various proposed substrates have
been soaked into SwADC crystals, as well as co-crystallized, however there has been no defining
electron density detected from either method. Diffraction data were collected at the Life Science
Collaborative Access Team (LS-CAT) beamline 21-ID-G at the Advanced Photon Source, Argonne
National Laboratory. The data were processed in MOSFLM

29, 30

and scaled in SCALA
SwADC

The

Table 19. Crystallographic Data Collection and Model
Refinement Statistics.
SwADC

structure

resolution (Å) (last shell)a

38.39 ‒ 1.95 (2.02 ‒ 1.95)

replacement using the structure of

wavelength (Å)
no. of reﬂections
observed
unique
completeness (%)a
Rmerge (%)a,b
multiplicity
⟨I/σ(I)⟩a

0.9786

determined

of

31.

by

was

molecular

a SbAD protomer (PDB ID 4ZBO) as

334092 (27317)
73627 (7275)
100 (100)
0.07611 (0.1883)
4.5 (3.8)
13.92 (7.06)
Model Refinement

the search model (see Table 19 for
data collection and refinement

no. of reﬂections in the work set 73600 (7271)
no. of reﬂections in the test set
3688 (349)
Rcryst (Rfree)
0.1719 (0.2068)
no. of residues
1025
no. of TLS groups
27
average B factor (Å2)c
protein atoms
35.94
solvent
35.84
root-mean-square deviation
bond lengths (Å)
0.012
bond angles (deg)
1.28
Ramachandran statistics
(favored/allowed/outliers)
98.5/1.5/0
aValues in parentheses apply to the high-resolution shell
indicated in the resolution row.
bR = ∑(||F | − scale ×| F
c
obs
calc||)/∑|Fobs|. Isotropic equivalent B
factors, including the contribution from TLS reﬁnement.

statistics).

SwADC

crystals

belonged to space group C2 with 4
molecules in the asymmetric unit.
As shown in Figure 34, the overall
fold of the SwADC protomer is
nearly identical to those of the
prototypical Family I ADCs, as well

as the recently described Family V enzymes like SbAD from Streptomyces bingchenggensis and
MppR from S. hygroscopicus, which are not decarboxylases 12, 32. This fold, dubbed the β-cone 33
or double barrel fold 34, consists of a large, antiparallel, 13-stranded β-sheet that forms the main
barrel and folds back on itself to form the side barrel. Unlike prototypical ADCs that are active as
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homododecamers, SwADC has a tetrameric quaternary structure similar to SbADC and MppR
(Figure 34).
Figure 34. (A) Rendering of the solventaccessible surface of SwADC showing
the extensive tetramer interface
formed by the long, interdigitating
loops (top). This interface is repeated
on the back side with the blue and pale
blue protomers. The pair of dimers is
held together (bottom) by short loops
that appear to “clip” the two dimers
together to form the tetramer. (B) The
ribbon diagram showing a single
protomer is oriented like the yellow
protomer in panel A. The main barrel
of the β-cone fold is colored pale blue,
with the “side barrel” colored green.
The dimer interface loops are colored
yellow, and the loops forming the
interface between the dimers are
colored orange. The section of the
polypeptide that is colored red is the
“active site loop” that may control
access to the active site. The catalytic
Lys122 is shown as a ball-and-stick
representation with purple carbon
atoms.

Although the tetramer in Figure 34 does not contain a ligand, only conserved waters, chains A
and C, represented by the pale yellow and pale blue protomers, had different active site
conformations than chains B and D, shown as orange and dark blue. Interestingly, the tetramer
for SwADC is a dimer of dimers. The two dimer pairs from each dimer are different, as opposed
to the two dimers differing from one another. Figure 35 illustrates these different active site
conformations, with the corresponding schematic representations and the relevant distances
provided in Figure 36.
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Figure 35. The two different active sites of SwADC, represented by (A) and (B), respectively. (A) Stereoview of the active site
in the SwADC structure showing conserved waters (refer to Figure 36 for relevant hydrogen bonding interactions and their
distances). (B) One putative new water molecule has been recruited by Glu84. In both panels, the experimental 2|Fo|−|Fc|
electron density map (magenta) and the simulated annealing composite omit 2|Fo| − |Fc| electron density map (green), both
contoured at 1.0σ, are drawn with a 2.0 Å radius around each atom of Lys122 and select water molecules. This figure and
subsequent figures showing crystallographic structures were rendered with the POVSCRIPT+ 35 modification of MOLSCRIPT36
and POVRAY.
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Figure 36. Schematic views of (A) one of the active sites of SwADC and (B) the other conformation showing potential hydrogen
bonding interactions and their distances (in Angstroms) in green.

Chains A and C (Figures 35 A and 36 A, conformation A) has three ordered water
molecules bound. In chains B and D (Figures 35 B and 36 B, conformation B) water molecule 3
from conformation A has been retained, water molecules 1 and 2 have been lost, and a new
water molecule (labelled “4” in Figures 35 B and 36 B) is bound to Glu84. However, the biggest
difference between the two active site conformations is that in conformation A, Arg114 exists in
a single conformation as evidenced by the well-defined electron density, and Tyr120 samples
multiple conformations such that much of the associated electron density is missing. In
conformation B, the opposite is true. Tyr120 takes a single conformation and the guanidinium
group of Arg114 is disordered. These two residues are not connected by hydrogen bonding or
van der Waals interactions of their side chains, nor do they communicate through a watermediated hydrogen bond network. In addition to this, the indole of Trp24 flips about 90° between
conformations A and B, and Val106 rotates about 180°. Perhaps all these changes are based on
a concerted change in the tetrameric structure, such that one version of the active site is better
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configured for catalysis than the other. However, the conformations of the active sites are lowest
energy forms of the protein under crystallization conditions, and so these subtle differences may
not be physiologically relevant. Thus, SwADC may be a cooperative enzyme, though our
preliminary kinetics on admittedly poor substrates do not suggest that this is the case.
Functional characterization. The biochemical function of SwADC remains elusive, though there
Table 20. Binding constants for α-keto acids with SwADC.

are indications that it can function as a pyruvate

α-keto acid

KD (mM)

aldolase-dehydratase. As a Family V enzyme of

pyruvate

10.1 ± 0.9

2-oxoglutarate

11.0 ± 1.4

2-oxoadipate

5.9 ± 0.7

the ADCSF, the binding constants of pyruvate
and other α-keto acids were measured (Table
20). The KD of pyruvate is twice as high as that
for SbAD. Surprisingly, given the number of rotatable bonds, 2-oxo-adipate has a somewhat
lower KD, suggesting that the enzyme might have a preference for longer, aliphatic side chains on
the α-keto acid (Table 20). Based on the space available in the active site and the array of residues
lining the pocket, it seemed that a 6-8 carbon long di-carboxylic acid might be a viable substrate.
Scheme 9. 2-hydroxymuconic acid (2HM) reacts with 4-oxalocrotonate tautomerase (4-OT) to produce 2-oxohex-3-enedioate
(OHD). SwADC then reacts to form an aldol.

Accordingly, 2-oxohex-3-enedioate (generated by 4-oxalocrotonate tautomerase from 2hydroxymuconic acid) was tested for activity with SwADC (Scheme 9). When 100 µM OHD was
incubated with 10 µM SwADC, there was a steady decrease in the absorbance due to cleavage or
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loss of conjugation of OHD (Figure 37). The
rate of decrease was dependent on both
the concentration of OHD and the
concentration

of

enzyme

(data

not

shown). The steady state kinetics of this
reaction were analysed for the wild type,
as well as three active site mutants:
Tyr120Phe, Tyr120Phe/Phe248Tyr, and
Figure 37. 100 µM 2HM was treated with 1 µM 4-OT for 20 min
before 10 µM SwADC was added. Scans were recorded every 4
minutes at 25 °C. The λ300nm is remaining 2HM, and λ236nm is OHD.

Asn118Glu (Table 20). The mutants were
selected for their possible catalytic and/or

binding roles based on homology to SbAD. Tyr120 is one of the residues that is disordered in one
conformation, but not the other. Perhaps Tyr120 needs to undergo conformational change in
order for a reaction to occur. To test this idea, Tyr120 was mutated to a Phe, as there is a Phe in
this position in SbAD. Phe248 was mutated to Tyr as it matches the residue in SbAD, which is
Tyr252. Phe248Tyr could not be obtained in soluble form, however the double mutant
Tyr120Phe/Phe248Tyr expressed and purified well, and the pair of mutations make this variant
more like SbAD. Lastly, Asn118 was mutated Glu, again to match SbAD.
Table 20. Steady state kinetics for SwAD WT and active site mutants with OHD, monitored at
236 nm.
SwADC
kcat, OHD (sec-1)
KM, OHD (µM)
kcat/KM (M-1 sec-1)
WT

0.010 ± 0.001

66.4 ± 16.3

151 ± 40

Y120F

0.042 ± 0.006

281.1 ± 67.2

149 ± 42

Y120F F248Y

0.018 ± 0.002

340.4 ± 57.5

53 ± 11

N118Q

No activity

-

-
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In other crystal structures (data not
shown), Arg114 appears to wave around the
active site, while Asn118 has continuous
electron density. SbAD, however, naturally
has Gln at this position, and continuous
electron density for Arg114 and Glu118. We
proposed that the longer side chain of Glu
Figure 38. 10 µM Swit reacted with 2-oxo-3-heptenedioic acid
for 2 minute scans at 30 °C.

for Asn118Glu may fix Arg114 in place,

altering binding or catalysis. Based on the results in Table 20, Tyr120Phe is about 4 times faster
at turnover, however the KM is higher. These two factors compensate to attain the same pseudosecond order rate constant. Perhaps the substrate binds Tyr120Phe in a different manner
resulting in a faster reaction. The double mutant had the lowest kcat/KM, however all of the SwADC
variants reacted quite slowly with OHD. The KM values suggest that OHD does not bind terribly
well. A seven-carbon compound like oxo-heptene-dioate, rather than the six-carbon OHD, could
conceivably fill the active site more completely and be a more efficient substrate.
To that end, 5-carboxymethyl-2-hydroxymuconic acid (CHM) was isomerized by CHM
isomerase, to yield 5-(carboxymethyl)-2-oxo-3-hexene-1,6-dioic acid (COHED). COHED was then
decarboxylated to 2-oxo-3-heptenedioic acid. When 2-oxo-3-heptenedioic acid was incubated
with SwADC, there was a time-dependent reduction in absorbance at all wavelengths, similar to
what was observed with OHD (Figure 38). The reaction was not characterized by steady state
kinetics as both CHM, CHM isomerase, and COHED decarboxylase were difficult to produce.
Efforts focused instead on identifying the product of the reaction with OHD by mass spectroscopy
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(MS)

and

nuclear

magnetic

resonance (NMR) (Appendix II).
Based upon MS data, it appears
unlikely that SwADC performs retroaldol cleavage of OHD. Instead, it
appears to simply hydrate the
double bond to give the aldol. Vinyl
pyruvate (8, Scheme 10 B) was also
treated with SwADC and the reaction
Scheme 10. The proposed reaction in (A) is observed in Figure 38. The
reaction in (B) has been confirmed by mass spectroscopy as well.

mixture analyzed by MS. As with

OHD, only the aldol product could be detected; there was no evidence of other products. There
was also no evidence of the aldol forms of OHD or 8 in standards that had not been incubated
with SwADC. The NMR data were inconclusive owing to the complicated spectra arising from the
mixture of compounds present. No cleavage products of either substrate were detected by
reverse phase HPLC.
Based on the close relationship between SwADC and SbAD, cinnamaldehyde and pyruvate
were used to test for aldol condensation activity in SwADC. SwADC was not able to catalyze the
aldol

condensation

with

these

substrates,

likely

Scheme 11. Reaction tested for SwADC based on the results of SbAD.

because the aromatic
group of cinnamaldehyde is too bulky and/or lipophilic for the SwADC active site. To test this, 3126

(2-furyl)acrolein was used as the acceptor substrate (Scheme 11). Both the condensation and the
retro-aldol cleavage (catabolic) reactions were characterized by steady state kinetics (Table 21).
It is difficult to say if the breakdown direction stops at the aldol, or a full retro-aldol cleavage
occurs. The aldol is difficult to detect via MS, and pyruvate does not appear on NMR spectra or
MS data for the catabolic process yet the fact that the enzyme catalyzes the aldol condensation
reaction between pyruvate and 10 to give the enone suggests that it should be able to catalyze
the retro-aldol reaction as well.
Table 21. Steady state kinetics for Scheme 11. SwADC was 0.5 – 1 µM. Reactions took place at 25 °C in 50 mM BIS-Tris pH 6.5
and monitored at 390 nm.
SwADC
kcat,10 (sec-1)
KM,10 (µM)
kcat/KM (M-1 sec-1)
kcat,12 (sec-1)
KM,12 (µM)
kcat/KM (M-1 sec-1)
WT

0.084 ± 0.006

2.99 ± 0.65

2.8 ± 0.6 x 104

0.09 ± 0.02

N118Q

0.068 ± 0.005

3.64 ± 0.82

1.9 ± 0.4 x 104

No Activity

Y120F F248Y

0.041 ± 0.003

1469.8 ± 252.2

27.9 ± 5.2

No Activity

42.02 ± 13.99

2.1 ± 0.9 x 103

The wild type SwADC and the two mutants tested all functioned in the aldol condensation
reaction (synthetic direction), with the Asn118Glu variant turning over at about the same rate as
the WT, and the Tyr120Phe/Phe248Tyr variant only slightly slower. Likewise, the WT and
Asn118Glu SwADC had the same Michaelis constant, indicating that the mutation likely did not
affect substrate binding. The Y120F/F248Y double mutant has a K M value for 10 almost 500-fold
higher than that of the WT enzyme. Since it was not possible to test both single mutants, it is not
clear whether this effect is due to Tyr120, Phe248, or the combination of the two. It is clear,
however, that the double mutant does not bind 10 well. Interestingly, only the WT enzyme
catalyzed the retro-aldol cleavage (catabolic direction) of 12. Again, since the signal loss at 390
nm was the method of detection, it is not possible to tell if the reaction stopped at the aldol,
which would eliminate the conjugation that gives rise to the absorbance signal. Interestingly,
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neither of the mutants were active. Perhaps they do not hold the substrate in the correct
orientation for reaction, or their KM is greater than 10 mM.
In any case, the function of SwADC is certainly distinct from those of the classical ADCs,
as well as the Family V enzymes SbAD, which is an aldolase-dehydratase
likely catalyzes the cyclization of a highly oxidized arginine derivative

12.

32,

and MppR, which

Comparisons of the

active sites shed light on the reasons for this (Figures 39 and 40). The residues responsible for
Schiff base chemistry are conserved: the active site lysine and the likely acid/base catalyst
glutamate that is within hydrogen bonding distance. In SwADC numbering, Arg114, Asn118, and
Val106 are the same between SwADC and MppR. However, there are significant differences, as
observed in Figure 39.
Figure 39. Stereoview comparing MppR and SwADC. The green peptide chain is MppR, and the blue is SwADC. The active site
lysine and likely acid/base catalyst glutamate are labelled according to SwADC, and are conserved in both proteins, along with
R114 and N118. There are numerous differences, however observed throughout the rest of the model. For instance, the
switching of Trp and Phe on the top portion, and the Met in MppR. Although the carboxylate-binding site appears to be
conserved, other residues in the active site aside from those that contribute to forming a Schiff base intermediate, are not.
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Figure 40. Stereoview comparing SbAD and SwADC. The dark blue peptide chain is SbAD, and the pale blue is SwADC. The
active site lysine and likely acid/base catalyst glutamate are conserved in both proteins, along with Arg114. There are
numerous differences, however observed throughout the rest of the model. Although the carboxylate-binding site appears to
be conserved, other residues in the active site aside from those that contribute to forming a Schiff base intermediate, are not.

A comparison of SwADC and SbAD (Figure 40) shows K122 and E84 are conserved, contributing
to Schiff base intermediate in the mechanism. Similar to Figure 39, although Arg114 is conserved,
it is facing in the opposite direction. We can now see the difference near Arg114 for the Asn118
in SwADC and Glu118 in SbAD. Mutating position 118 in either enzyme alters the steady state
kinetics, and suggests a role in catalysis and/or substrate binding. The tertiary structures of
SwADC and the known decarboxylases are extremely similar (RMSD <2.0Å for all common Cα
atoms). The loss of decarboxylase activity is the result of a series of key amino acid substitutions
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and subtle structural rearrangements. Thus, there is significant reaction diversity even within a
single family of the ADCSF.

5.4 Conclusions
While SwADC is very weak with the substrates tested, it can catalyze the aldol
condensation and subsequent dehydration of pyruvate and a number of aldehydes to yield the
corresponding enones. However, MS data points towards hydration only in the catabolic
direction, noted by the hydrations of vinyl pyruvate (2) and OHD (8). Future work will focus on
characterizing the other members of the proposed catabolic gene cluster with the goal of
identifying the physiological substrate for this catabolic pathway.
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CHAPTER VI: CONCLUSIONS
Despite the retention of an overall tertiary fold and a Schiff base intermediate in their
mechanisms, there is significant diversity in terms of substrate specificity and the reactions
catalyzed among enzymes of Family V of the ADCSF. MppR was the first Family V enzyme to be
characterized. It was shown to catalyze the cyclization of 4-hydroxy-2-ketoarginine, as well as
aldol condensation of 4-imidazolecarboxaldehyde and pyruvate with subsequent dehydration to
yield the enone 1. The latter of these two reactions is also catalyzed by SbAD 2, an aldolasedehydratase from Streptomyces bingchenggensis that will accept a range of aldehyde substrates
and SwADC, an enzyme of unknown function from Sphingomonas wittichii. Although all three
enzymes can catalyze the aldol condensation reaction, it is only the primary reaction for SbAD.
In addition, there are differences in the substrate preferences in all cases. Subtle differences in
the residues lining the active sites of these 3 enzymes accounts for their different reactions and
substrate specificities. SbAD is most efficient with aldehydes having a bulky, substituted-aromatic
group, like 4-nitrocinnamaldehyde, whereas SwADC was only observed to catalyze the reaction
with the smaller, more polar 3-(2-furyl)acrolein. Transient kinetic studies of the reaction of
cinnamaldehydes with pyruvate catalyzed by SbAD, together with KIE analysis, allowed us to
propose a mechanism for this ADCSF enzyme. The order of addition was not conclusive from
transient kinetics alone, so inhibitors were used to determine that the mechanism is ordered
sequential with pyruvate likely binding first. Mutation of residues in the active site of SbAD
identified the key residues for catalysis. Binding constants measured for pyruvate and
cinnamaldehyde show that none of the residues tested had a significant effect on substrate
binding, suggesting that substrate binding is driven more by van der Waals forces and size/shape
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complementarity between the substrate and active site. Tetramer interface mutants also suggest
that SbAD may undergo a conformational change during catalysis, though there is no evidence
of cooperativity in any of the kinetics data. The enzyme Swit_4259 from Sphingomonas wittichii
(SwADC) also maintained the overall fold of ADC, but appears to function as a hydratase or
aldolase dehydratase, as evidence for the retro-aldol reaction is lacking. Based on the collected
results, SwADC appears to violate the principle of reversibility, whereby the reaction catalyzed in
one direction should also be catalyzed in the reverse. All three enzymes in Family V lack the key
decarboxylase residues found in Family I: the arginine that orients the acetoacetate in the active
site for nucleophilic attack, and the second glutamate, whose negative charge aids in
decarboxylation. The loss of those key residues, but retention of the lysine nucleophile and likely
acid/base glutamate, might lead one to believe that the Family V enzymes would have similar
substrate specificities and activities. However, even these three incredibly similar enzymes
illustrate the variety of reactions catalyzed in Family V alone. All three enzymes are also found in
organisms noted for secondary metabolism, and based on gene context, may aid in those
biosynthetic (SbAD) or aromatic hydrocarbon degradation (SwADC) processes.
While much has been learned about SbAD and SwADC, several outstanding questions
remain. The biological function of SbAD is still unknown. Studying a close homolog from another
bacterium might offer clues to its biological function. To this end, we have identified two species
with SbAD homologs having greater than 50% sequence identity: Burkholderia terrae
(WQE_44883, 57%) and Actinobacteria bacterium OK006 (OK006_7770, 91%). Real time PCR
could be used to identify growth conditions for one or both species that result in expression of
the SbAD homologs. Comparative metabolomics experiments using the instrumentation in the
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Shimadzu Laboratory for Advanced and Analytical Chemistry could identify compounds that are
only present when these genes are expressed. Then, performing the same experiment in knockout strains, we should be able to identify a small number of compounds that might be associated
with the SbAD homolog. Another outstanding question regarding catalysis in SbAD is the number
of protons moving in the reaction. This might be answered with a proton inventory experiment,
which can detect the coupling of several proton transfers in a single step 3. Since the pH rate
profile has been done, a pD profile would be needed next. The pH/pD at which the reactions in
H2O and D2O give the same turnover number would be optimal for the proton inventory,
detecting how many protons are in flight during turnover. The methods to investigate SbAD can
also be applied to SwADC. SwADC requires more substrate specificity experiments, transient
kinetics to see if there is any burst phase in the reaction, and single turnover to gather rate
constants. Another method to detect an intermediate could be to incubate the enzyme with
substrate, use NaBH4 to reduce the imine to an amide, and then use mass spectroscopy to
determine what has bound. In the case of an isomer bound, a chiral column for HPLC may be able
to distinguish the compound based on signal, retention time, and comparison to known
compounds. Overall, Family V contains enzymes that catalyze a variety of reactions; it may be
that the only factor common to most ADCSF enzymes is the Schiff base chemistry. This work has
contributed to our knowledge of the structure-function relationship in proteins and could
potentially increase the reliability of function annotations for ADCSF sequences in genome
sequence databases.
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APPENDIX I: SbAD
Genomic context of the gene encoding Sbi_00515.
Gene
Product

Length
(aa)

Annotation

Closest characterized homolog

Identity
(%)

Sbi_00514 160

+ Urease accessory protein

UreD, Streptomyces mirabilis

79

Sbi_00515 265

-

MppR, Streptomyces
hygroscopicus

39

Sbi_00516 205

+ 2,4-DAPG biosynthesis
transcriptional repressor PhlF

Mycofactocin system
transcriptional regulator,
Rhodococcus sp. AD45

36

Sbi_00517 219

-

None

~

Sbi_00518 133

+ Stress responsive alpha-beta
barrel domain protein

None

~

Sbi_00519 294

+ Taurine catabolism dioxygenase

Alpha-ketoglutarate-dependent
taurine dioxygenase,
Burkholderia caribensis MBA4

46

Sbi_00520 188

+ Hypothetical protein

FcoT, type III thioesterase,
Mycobacterium tuberculosis

41

Sbi_00521 133

+ Acyl carrier protein

MelD protein, Melittangium
lichenicola

34

Sbi_00522 1813

+ Modular polyketide synthase

None

~

Sbi_00523 485

+ Beta-ketoacyl synthase

Ketosynthase-acyltransferase didomain from module CurL of the
curacin A polyketide synthase,
Moorea producens 3L

41

Sbi_00524 524

+ Long chain fatty acid-CoA
ligase

Dicarboxylate-CoA ligase PimA,
Streptomyces sp. AA4

54

Sbi_00525 437

+ Cytochrome P450

Cytochrome P450 eryF,
Saccharopolyspora erythraea

36

Sbi_00526 254

+ Acetoacetate decarboxylase

Acetoacetate decarboxylase,
Clostridium acetobutylicum
ATCC 824

56

Sbi_00527 514

-

Hypothetical protein

None

~

Sbi_00528 528

-

Hypothetical protein

None

~

Acetoacetate decarboxylase

TetR family transcriptional
regulator
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141

142

143
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APPENDIX II: SwADC
(LC)MS; Negative polarity Swit WT
Sample
Buffer (20mM Ammonium acetate pH 7.0)
Buffer (20mM Ammonium acetate pH 7.0)
[intensity > 300]

2mM Sodium pyruvate standard
2mM 2KP standard
2KP + Swit WT

2KP + Swit Y120F (ZM -80°C stock)

2mM 2-HM

2mM 2-HM + 4-OT

2mM 2-HM + 4-OT + Swit WT

2mM 2-HM + 4-OT + Swit Y120F (ZM -80°C
stock)

2mM CHM

2mM CHM + CHMI

2mM CHM + CHMI + Swit WT

m/z
87.15
105.20
189.10
245.45
301.80
361.45
87.20
113.20
87.15
113.20
131.20
87.20
113.20
131.20
113.20
157.15
173.15
113.20
131.20
157.15
173.15
175.15
87.20
113.20
131.20
157.15
173.15
175.15
86.95
113.15
131.20
157.15
173.10
175.10
215.15
217
230.20
195.05
215.15
217
231.15
195.05
215.15
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Intensity
226
980
340
440
400
550
2865
4000
558
2100
3500
365
2400
5000
4000
16000
89
4000
400
10672
117
390
700
1500
4500
3000
213
6152
369
1357
1000
4364
265
7960
44602
4000
168
11600
725
3129
875
15500
2141

2mM CHM + CHMI + Swit Y120F

2mM CHM + CHMI + COHED

2mM CHM + CHMI + COHED + SbAD WT

2mM CHM + CHMI + COHED + SbAD Y120F

2mM CHM + CHMI + COHED + OHEDH

217.05
231.15
187.15
189.10
189
195.05
215
217
231.15
169.90
213
111.10
171.15
189
195.05
217
217
171.15
195.05
189.05
231.1
171.05
189.05
195.05
217.05
231.15
171.15
189.05
195.05
215.10
217.05
231.10

10 µL injections.
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3548
1162
646
2678
2000
22000
2000
4100
1500
401
665
6600
3200
800
13100
2615
3000
3800
18200
2327
800
6200
4100
22800
4000
1600
6200
6200
15500
2100
4100
1500
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Hands-on training of instrumentation, data collection, and analysis of
triple-axis spectrometer, small angle neutron scattering, nano-scale
ordered materials diffractometer, and liquids reflectometer at Oak
Ridge; X-ray fluorescence microscopy, small angle X-ray scattering,
coherent X-ray diffraction at Argonne

UW-Milwaukee
October 2012

Research Computing Boot Camp
Introduction to UNIX and parallel computing

UW-Milwaukee
Fall 2012

Responsible Conduct of Research Seminar Series
Weekly lectures and discussions about ethics in research; research
grant provided by NSF required training

UW-Milwaukee
2010 – 2012

Teaching Assistant for Lecturer Gloria Freschl:
Introductory General, Organic, and Biochemistry
for Nursing Students
Discussion and laboratory instructor for fall, spring, and summer
academic semesters, as well as weekly tutoring hours for all
introductory level chemistry courses offered

UW-Milwaukee
Summer 2011

Project Assistant
Organized and cleaned teaching laboratory stock rooms

MEMBERSHIPS







American Chemistry Society
American Crystallographic Association
American Society for Biochemistry and Molecular Biology
Biophysical Society
Milwaukee Area Structural Biology Interest Group
Protein Society

LANGUAGES



English – native
French – limited working proficiency
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